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Abstract 
 
 
Multiple areas along the neuroaxis mediate pain modulation and perception. Dysfunction at 
any of these stations can have devastating consequences that result in pain chronification and 
in the surfacing of emotional and cognitive disturbances. In the past decade, it was 
demonstrated that these comorbidities frequently associated with chronic pain also manifest in 
the animal model, paving the way for further research on the underling pathophysiology. 
However, conflicting observations have been published probably as a result of experimental 
heterogeneity. This prompted us to further characterize emotional and cognitive behaviour 
alterations in a rodent model of chronic neuropathic pain – the spared nerve injury (SNI).  
 
In the first set of experiments, the effect of chronic neuropathic pain was studied in the context 
of ageing. We observed an age-related increase of anxiety-like behaviour in the elevated-plus 
maze (EPM), which was further augmented in young and old males, but not mid-aged SNI 
animals. On the contrary, only SNI mid-aged animals had a depressive-like phenotype in the 
forced-swimming test (FST) when compared to age-matched controls. SNI mid-aged animals 
had also an impaired ability to perform a reversal learning task when compared with the 
respective age-matched controls. In this task, the SNI lesion affected neither young nor old 
groups, although in the last, controls themselves had a poorer performance. In fact, in this 
cognitive domain ageing was a major determinant of incapacity. Ageing was also demonstrated 
to have a mild negative influence in the performance of a spatial working memory (WM) but not 
in a long-term spatial memory – Morris water maze (MWM). The SNI lesion had no observable 
effect in both WM and MWM.  
 
In the second set of experiments, the effect of pain lateralization was accessed in young rats. 
Left-sided (but not right-sided) SNI was shown to be anxiogenic in the EPM. On the contrary, 
right-sided (but not left-sided) SNI was detrimental in all prefrontal cortex (PFC)-dependent 
cognitive paradigms, namely WM, reversal learning (in the attentional-set shifting task; ASST) 
and response inhibition (impulsivity). Neither right- nor left-side SNI affected the performance in 
the MWM.  
 
	  x	  
These observations indicate that both the age of the animal at the pain onset as well as the 
location of pain are determinant in the behavioural outcome on emotional and cognitive 
paradigms. Additionally, our behavioural observations suggest that the PFC has a major role in 
the observed emotional and cognitive shifts occurring after SNI installation.  
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Resumo 
 
 
A modulação e percepção da dor dependem da contribuição de várias áreas ao longo do 
neuro-eixo. A disfunção deste eixo pode resultar em consequências devastadoras que incluem 
a cronificação da dor e a manifestação de perturbações emocionais e cognitivas. Na última 
década, demonstrou-se que estas comorbilidades associadas a estados de dor crónica 
também se manifestavam no modelo animal, o que abriu novas perspectivas de investigação 
sobre os mecanismos subjacentes. No entanto, dados contraditórios têm vindo a ser 
publicados quanto à natureza destas manifestações. Este cenário esteve na base dos estudos 
desta tese, que pretenderam aprofundar a caracterização das alterações do comportamento 
emocional e cognitivo num modelo de dor crónica neuropática – o modelo SNI (spared nerve 
injury). 
 
No primeiro conjunto de experiências, o efeito da dor crónica foi estudado no contexto do 
envelhecimento. Com o envelhecimento observamos um aumento do comportamento do tipo 
ansioso no paradigma elevated-plus maze (EPM) e que este efeito era potenciado nos animais 
novos e velhos submetidos à lesão neuropática SNI. Pelo contrário, apenas o grupo de meia-
idade submetido ao SNI apresentava um comportamento do tipo depressivo no teste do 
forced-swimming (FST) quando comparado com o respectivo controlo da mesma idade. O 
mesmo grupo SNI de meia-idade mostrou também uma capacidade reduzida de 
aprendizagem reversa, o que não se verificava nos grupos de animais mais novos ou mais 
velhos embora, nestes últimos, os próprios controlos tenham tido um mau desempenho. De 
facto, neste paradigma o aumento da idade revelou-se um factor determinante de insucesso. 
O envelhecimento estava também associado a uma deterioração do desempenho numa tarefa 
de memória de trabalho (WM; working memory) não havendo no entanto qualquer influência 
na tarefa de memória de longo prazo (MWM; Morris water maze). A lesão SNI não teve 
qualquer influência no desempenho destes paradigmas pelos animais dos diferentes grupos 
etários.   
 
No segundo conjunto de estudos, avaliou-se o efeito da lateralidade da dor em animais jovens. 
A lesão SNI esquerda, (mas não a direita), resultou no aumento do comportamento do tipo 
	  xii	  
ansioso no EPM. Pelo contrário, a lesão SNI direita, (mas não a esquerda), induziu um pior 
desempenho nos paradigmas de comportamento cognitivo, nomeadamente em todos aqueles 
com um componente prefrontal (prefrontal cortex; PFC): WM, aprendizagem reversa (no 
contexto de um paradigma de attentional-set shifting task; ASST) e controlo da resposta 
impulsiva. A lesão SNI, independentemente do lado onde era instalada, não teve qualquer 
efeito na execução do MWM. 
 
Os nossos dados indicam que, quer a idade do individuo aquando da instalação da neuropatia, 
quer o lado do corpo onde esta se localiza, influenciam o desempenho em paradigmas de 
comportamento emocional e cognitivo. Resulta também das nossas observações que o PFC 
tem um papel determinante nas alterações comportamentais observadas após a instalação da 
neuropatia.  
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Introduction
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2
1. INTRODUCTION 
 
 
1.1. Pain 
 
“It was once thought the mechanisms that subserve pain would be entirely revealed if we applied noxious stimuli 
to the skin and then mapped the pathways taken by the nerve impulses through the spinal cord and brain. 
Unfortunately, pain mechanisms are not as simple as this.” 
 
in The Challenge of Pain (Melzack and Wall, 1982) 
 
 
Written accounts on pain origins and treatments are as almost old as the invention of written 
word itself. Pain was regarded by ancient peoples as something controlled by superior forces 
on which the individual had little or no control. In fact, the word “Pain” has its roots in both 
Greek and Latin words poine and poena, meaning penalty or punishment (Finger, 1994). It 
was not until the seminal works of Max von Frey (1852-1932) and Friedrich Kiesow (1858-
1940) on the role of free nerve endings as “pain receptors” that pain started to be recognized 
has a separate modality, subserved with distinct physiological machinery (Finger, 1994). By 
the same period, Alfred Goldscheider (1858-1935) among others, defended the idea that the 
same receptors would simultaneously convey innocuous touch and pain sensation, the 
resulting outcome differing as a function of the stimulus intensity. Specificity and pattern 
theories, as they become recognized, bear strengths and weaknesses. On the one hand, the 
specificity model had a solid physiological basis but simultaneously imposed a fixed relation 
between stimulus intensity and pain perception. Innumerable descriptions of severely wounded 
soldiers from the battle field claiming to feel no pain (Beecher, 1959) or the evocation of pain 
triggered by light touch in patients suffering from causalgias1 would indicate differently (Baron 
et al., 2010). On the other hand, the pattern model accounted for summation phenomena but 
totally disregarded the role of free nerve endings. Melzack and Wall extensively discussed these 
points in their breakthrough article and advanced a new theory: the gate-control theory 
(Melzack and Wall, 1965). This model hypothesized that peripheral information related to light 
touch and pain sensation was modulated by specific interneurons located in the substantia 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Term coined by Silas Weir Mitchell (1829-1914), from the Greek words Kausus (heat) and algos (pain). 
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gelatinosa of the spinal cord dorsal horn (the gate) before reaching higher centers in the brain 
(figure 1). The ascending output from the dorsal horn resulted from the reciprocal interaction 
between these spinal interneurons and large-diameter (innocuous) or small-diameter 
(nociceptive) primary afferent fibers. In the first case this would result in an overall decrease of 
transmission (“closing the gate”) and in the second in a net increase (“opening the gate”). The 
gate-control theory was subsequently reanalysed, reformulated and restated in the light of new 
data incorporating, for instance, the contribution of descending information from the brain 
(Wall, 1978; Melzack and Wall, 1982; Lima, 1996; Wall, 1996). Importantly, the gate-control 
theory was the first pain model that integrated the notion of central modulation.  
 
 
 
Figure 1. The gate-control theory. (left) Explanatory diagram as published in the original article by Melzack and 
Wall (1965), showing the interaction between two peripheral systems of fibers, large-diameter (L) and small-
diameter (S) primary afferent neurons, and the substantia gelatinosa, on the first central transmission cells (T). 
The model provided a theoretical framework for the central modulation of the output of T based on balance 
between the two concurring systems. (right) A more complex version of the model integrating multiple ascending 
systems and the contribution of descending controls, was envisaged by Melzack and Casey (1968). 
 
 
Pain is currently defined by the International Association for the Study of Pain (IASP) 
Committee on Taxonomy as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” (Merskey et al., 
1979; Lindblom et al., 1986). As a sensorial experience pain is unique in many aspects. For 
instance, unlike other sensations that tend to adapt after continuous and uniform stimulation, 
pain does not adapt to the continuous presence of the nociceptive stimulus, tending in fact to 
get progressively worse (Cervero, 2009). IASP definition reflects not only this specificity but 
also the heterogeneity associated with pain manifestations.  
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1.2. Anatomofunctional organization of the nociceptive system 
 
“I have elsewhere put forward a view that there has been evolved in the skin ““a special sense of its own 
injuries””. There is considerable evidence that the skin is provided with a set of nerve-endings whose specific 
office it is to be amenable to stimuli that do the skin injury, stimuli that in continuing to act would injury it still 
further”  
Sherrington, 1903 
 
 
1.2.1. Nociceptors 
 
The set of nerve-endings mentioned by Sherrington (1903) would be coined a few years later 
by himself as nociceptors (Sherrington, 1906). Up-to-date literature defines the nociceptor as a 
primary afferent nerve fiber that is suited to encode relevant properties of the noxious stimulus 
(Djouhri et al., 2006; Treede, 2009; Dubin and Patapoutian, 2010). The complete absence of 
these structures in the brain or cartilage determines that pain cannot be elicited from these 
organs. On the contrary, pain is nearly the only sensation that can be elicited from the cornea, 
dura mater and dental pulp, indicating a predominance of nociceptors over other afferent 
terminals (Mense, 2009).  
 
The nociceptor is a pseudounipolar cell and shares with other primary sensory neurons the 
same basic organization (Woolf and Ma, 2007). They are predominantly unmyelinated (C-
fibers) or thinly myelinated (Aδ-fibers) but thick, heavily myelinated fibers (Aα/β), normally 
responsible for transmission of innocuous information, have also been reported to conduct 
noxious information (Djouhri and Lawson, 2004; Todd, 2009). Conditions associated with loss 
of function in thinly myelinated or unmyelinated fibers interfere with pain sensation while 
sparing light touch sensation, whilst pain is preserved in conditions selectively affecting large 
myelinated Aβ fibers (Raja et al., 1988; Scherer, 2006; Verhoeven et al., 2006). A similar 
effect can be elicited by ischemic compression of a limb resulting in the blockade of large 
myelinated fibers with concomitant loss of tactile but not pain sensation (Landau and Bishop, 
1953). The different degree of myelination of these two populations, C and Aδ, imposes that 
the latter conducts nerve impulse faster than the former therefore transmitting the so called 
“first pain”, i.e., the sharp pain that immediately follows a noxious pinch, pinprick or heat. 
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“Second pain”, on the other hand, is transmitted by the unmyelinated nociceptors in the form 
of a more diffuse, dull and burning sensation that persists after the “first pain” (Julius and 
Basbaum, 2001; Meyer et al., 2005; Basbaum et al., 2009; Porreca, 2010). The 
unmyelinated C-fiber population is morphofunctionally diverse. It has been shown that it 
consists of two major neurochemical groups (Hunt and Rossi, 1985; Snider and McMahon, 
1998; Craig, 2003; Mense, 2009; Todd, 2009). One group expresses neuropeptides like 
calcitonin gene-related peptide (CGRP), substance P (SP), galanin and somatostatin, whereas 
the other contains fluoride-resistant acid phosphatase activity (FRAP) and binds the plant lectin 
Griffonia simplicifolia isolectin B4 (IB4) (Nagy and Hunt, 1982). These two neural populations 
named peptidergic and non-peptidergic, respectively, differ in their terminations at the dorsal 
horn. Peptidergic afferent fibers project to lamina I and outer lamina II whereas non-peptidergic 
terminate mainly in inner lamina II (Coimbra et al., 1974; Braz et al., 2005; Basbaum et al., 
2009). Ascending pathways from these sites are segregated suggesting differential 
contributions to supraspinal pain processing (Braz et al., 2005). Peptidergic and non-
peptidergic populations are functionally distinct in terms of their electrophysiological proprieties 
(Stucky and Lewin, 1999) and, when selectively ablated, noxious heat and noxious mechanical 
pain sensitivity dissociate to a certain extent (Cavanaugh et al., 2009). A third population of 
nonpeptidergic unmyelinated afferents that do not bind IB4 and is sensitive to noxious cold has 
also been identified (Dhaka et al., 2008). 
 
On its peripheral extremity, the nociceptor is usually an unencapsulated free nerve ending that 
branches from the main axon (Dubin and Patapoutian, 2010). This is the case for all C-fibers 
but not for Aδ-fibers as some, for instance, innervate D-hairs afferents (Mense, 2009; Todd, 
2009). The repertoire of transduction molecules expressed at the periphery confers to the 
nociceptor the modality (thermal, mechanical or chemical) and the range of sensibility 
(Basbaum et al., 2009). In contrast to innocuous receptors, nociceptors can frequently be 
activated by more than one type of stimulus, i.e. they are polymodal (Ringkamp and Meyer, 
2009). Coherently with its primary function, the threshold of a nociceptor is set below the 
tissue damage intensity signalling imminent tissue damage (Treede, 2009). Adequate stimuli 
include extreme temperatures (> 40°C–45°C or < 15°C), intense pressure and an array of 
potentially harmful substances (Raja et al., 1988; Dubin and Patapoutian, 2010). These 
nociceptive morphofunctional units are phylogenetically conserved across animal species 
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suggesting a paramount biological asset for species survival (Andrew and Greenspan, 1999; 
Lewin and Moshourab, 2004; Foulkes and Wood, 2008). 
 
1.2.2. Ascending nociceptive transmission 
 
Primary afferents terminate in the spinal cord dorsal horn arranged in a modality specific 
manner (Todd, 2009). Marginal zone and substantia gelatinosa, which according to Rexed’s 
nomenclature (1954) correspond to spinal cord laminae I and II, receive the majority of 
nociceptive afferents, with a smaller part terminating in the deep dorsal horn (lamina V). 
Deeper laminae III-V receive mainly primary afferents involved in low-threshold signalling, 
namely, tactile, hair and proprioceptive sensation (Todd, 2009). Conversely, inputs from 
descending projections arising from various areas of the brain (see section 1.2.3.) target dorsal 
horn neurons and participate in the endogenous modulation of the spinal nociceptive 
transmission (Millan, 2002; Gebhart, 2004; Vanegas and Schaible, 2004; Almeida et al., 
2006; Pertovaara and Almeida, 2006). Dorsal horn spinal cord neural population is composed 
by two main types of neurons classified according to their axonal projections: i. neurons with 
short axons that communicate locally designated as interneurons; ii. neurons with long axons 
that communicate supraspinally, designated as projection neurons (Todd, 2009). Projection 
neurons are not uniformly distributed within a spinal cord segment. The vast majority 
concentrates in lamina I and the remaining disperses in deeper laminae and gray matter 
around the central canal, although segmental heterogeneity has also been observed (Al-Khater 
et al., 2008). Most of these lamina I projection neurons express the neurokinin 1 receptor 
(NK1r) for SP. Similarly, laminae III and IV neurons whose dorsal dendrites extend to lamina I 
express NKr1 as well (Ding et al., 1995; Li et al., 1996; Marshall et al., 1996; Li et al., 1997; 
Li et al., 1998; Todd et al., 2000; Spike et al., 2003). This is anatomically coherent with the 
termination site of peptidergic primary afferent terminals mentioned in the previous section 
(1.2.1.). Coherently, saporin derived ablation of NK1r expressing cells leads to a decreased 
mechanical and thermal hyperalgesia in several models of inflammatory and neuropathic pain 
(Mantyh et al., 1997; Nichols et al., 1999), in accordance with the expected role of lamina I 
afferent terminals on pain. 
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Based on supraspinal termination targets of spinal projection neurons, a number of tracts are 
defined that include the spinothalamic, spinoreticular, spinomesencephalic, cervicothalamic, 
spinohypothalamic and spinothelencephalic (Basbaum and Jessel, 2000; Tracey, 2004; Lima, 
2009). The spinothalamic tract is in all aspects the most studied tract being therefore the 
archetype of the nociceptive ascending pathway. It is classically divided in two major ascending 
systems, the lateral (or neospinothalamic) responsible for the sensory-discriminative properties 
of pain and the medial (or paleospinothalamic) related with its affective-motivational aspects, 
which terminate in the posterior lateral sensory nuclei and in the medial nuclei of the 
thalamus, respectively (see figure 2; Melzack and Casey, 1968; Treede et al., 1999; Treede, 
2002; Lima, 2009). Lateral thalamic neurons project thereafter to the primary and secondary 
somatosensory cortex, whereas medial thalamic send information, among other cortical areas, 
to the anterior cingulate cortex (Treede et al., 1999; Treede, 2002; Lima, 2009). Spinal cord 
and thalamic neurons that are part of the lateral tract have small receptive fields and encode 
accurately the noxious stimulus properties (Kenshalo et al., 1979; Kenshalo et al., 1980; 
Peschanski et al., 1980), while those neurons integrating the medial system possess large 
receptive fields and the activity pattern does not encode the stimulus properties (Giesler et al., 
1981). These anatomofunctional properties of the lateral and medial systems reflect their 
involvement in the sensory-discriminative and affective-motivational aspects of the nociceptive 
ascending transmission.  
 
Nociceptive ascending pathways are traditionally believed to target the contralateral brain. This 
is mostly true for the spinothalamic pathways described above but cannot be generalized to all 
the ascending systems. The vast majority of ascending tracts project in a bilateral fashion, with 
variable contralateral or ipsilateral contribution (Lima, 2009). Moreover, it became clear in 
studies using retrograde tracers that the sidedness of a particular tract can actually vary 
according to the spinal cord origin level and/or laminae (Al-Khater et al., 2008). The functional 
implications of this lateralized organization have been a matter of debate particularly in those 
aspects referring to frequency, threshold, modulation and functional impact of pain.  Merskey 
and Watson in 1979 based on a systematic review of the literature available at the time, 
concluded that pain, when lateralized, occurred mostly on the left side (Merskey and Watson, 
1979). The authors attributed the lateralized effect to a diminished efficiency of the right 
hemisphere in processing sensory information. Subsequently, Hall and colleagues tested this 
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hypothesis and concluded that pain frequencies were identical on both sides (Hall et al., 
1981). Ensuing research favored this view (Campbell et al., 1985; Margolis et al., 1985) the 
sole exception being the trigeminal neuralgia that presents a clear bias toward the right side 
(Katusic et al., 1990). This result is not, however, extensible to other facial pain conditions 
(Lam and Remick, 1988; Harness and Chase, 1990). Similarly, side-related differences in the 
threshold to painful stimulation were initially reported (Wolff and Jarvik, 1964; Wolff et al., 
1965; Haslam, 1970; Murray and Safferstone, 1970; Gobel and Westphal, 1987) but these 
did not find support in other studies (Newton and Mumford, 1972; Seltzer et al., 1992; Schiff 
and Gagliese, 1994; Gagliese et al., 1995). Lateralized organization of pain pathways has 
however been suggested to have implications for pain-related emotional arousal, with left pain 
resulting in greater emotional disturbance (Schiff and Gagliese, 1994; Gagliese et al., 1995).  
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Figure 2. Main ascending and descending pain pathways (Basbaum et al., 2009). Primary afferent terminals 
transmit nociceptive information from the periphery to projection neurons at the dorsal horn of the spinal cord. 
Information reaching the somatosensory cortex via thalamus and prefrontal cingulate/insular cortices via 
amygdala (Amy), originates in different populations of projection neurons. These pathways are related respectively 
with the sensory/discriminative and emotional/affective components of pain. The ascending nociceptive input is 
modulated by the periaqueductal gray/rostral ventromedial medulla (PAG/RVM) descending axis that acts upon 
the spinal projection neurons and terminal axons of peripheral sensory fibers. 
 
 
Progressively, a small number of brain areas have been shown to present a marked pain 
processing lateralization. This is the case of frontal operculum (acute painful laser radiant heat 
pulses in the human; Schlereth et al., 2003) and amygdala (Amy) (persistent inflammatory 
pain in the rat; Carrasquillo and Gereau, 2008; Ji and Neugebauer, 2009). In both cases, 
independently of stimulation side, the activation/processing in the brain was biased toward the 
left and right sides, respectively.  
 
1.2.3. Descending modulation of pain 
 
Beecher observations of extensively wounded soldiers (Beecher, 1959) with minimal pain 
complaints anticipated a non canonical relation between injury and perceived pain as predicted 
by the specificity theory. By the same period, the first observations of cortical modulation of 
spinal cord and trigeminal sensory information (Hagbarth and Kerr, 1954; Hernandez-Peon 
and Hagbarth, 1955) started to unveil the existence of an endogenous pain control system. In 
a seminal work, Reynolds reported that complete analgesia could be elicited through electrical 
stimulation of the periaqueductal gray (PAG) allowing an open abdomen surgery in rat without 
the support of any chemical anaesthetic (Reynolds, 1969). Soon it became clear that other 
sites were also involved in descending inhibition of pain, including the Raphe Magnus nucleus 
and adjacent reticular formation [rostral ventromedial medulla (RVM)], which were shown to 
project directly to the spinal dorsal horn and to mediate electrical/pharmacological induced 
analgesia (Basbaum et al., 1976; Basbaum et al., 1977; Basbaum and Fields, 1979). In fact, 
direct application of morphine (a paradigmatic opioid analgesic) in sites where analgesia could 
be elicited by electric stimulation produced the same effect (Pert and Yaksh, 1974; Jacquet 
and Lajtha, 1976). Furthermore, the specificity of the effect was ascribed to opioid µ-receptor 
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as it was reverted with opioid antagonist naloxone (Akil et al., 1976). The same effects of PAG 
stimulation/naloxone inhibition were also observed in humans within a few years after these 
pioneering finding (Adams, 1976). The set of information collected led to the conceptualization 
of a descending modulatory system centred in the PAG-RVM-spinal cord axis and functionally 
inhibitory in its overall effect on pain perception (Basbaum and Fields, 1978, 1984). In the 
following years it became clear that supraspinal modulation of pain was in every aspect far 
more complex than anticipated by the initial findings (Stamford, 1995; Lima and Almeida, 
2002; Millan, 2002; Gebhart, 2004; Almeida et al., 2006; Ossipov et al., 2010). Other 
supraspinal areas involved in descending modulation are now recognized not only in the 
brainstem, such as the dorsal reticular nucleus (DRt; Almeida et al., 1996; Almeida et al., 
1999) or the caudal ventrolateral medulla (CVLM; Tavares and Lima, 2002; Pinto-Ribeiro et al., 
2011), but also in the hypothalamus (Pinto-Ribeiro et al., 2008) or cortex (Zhang et al., 2005). 
Importantly, descending modulation is presently known also to operate in a facilitatory fashion 
(Lima and Almeida, 2002; Porreca et al., 2002; Almeida et al., 2006) in addition to its well-
known antinociceptive action (Pertovaara and Almeida, 2006).  
 
 
1.3. Chronic neuropathic pain 
 
“We have some doubt as to whether this form of pain [causalgia] ever originates at the moment of the wounding; 
but we have been so informed as regards two or three cases. Certain it is that, as a rule, the burning arises later, 
but almost always during the healing of the wound. Of the special cause which provokes it, we know nothing, 
except that it has sometimes followed the transfer of the pathological changes from a wounded nerve to 
unwounded nerves, and has then been felt in their distribution, so that we do not need a direct wound to bring it 
about. […] The part itself is not alone subject to an intense burning sensation, but becomes exquisitely 
hyperaesthetic, so that a touch or a tap of the finger increases the pain. Exposure to the air is avoided by the 
patient with a care which seems absurd, and most of the bad cases keep the hand constantly wet […]. As the 
pain increases, the general sympathy becomes more marked. The temper changes and grows irritable, the face 
becomes anxious, and has a look of weariness and suffering […]. At least the patient grows hysterical, if we may 
use the only term which covers the facts.”  
 
in Gunshot Wounds and Other Injuries of the Nerves (Mitchell et al., 1864) 
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Pain is a main motivation for seeking medical assistance. When persistent, it can be highly 
incapacitating to the individual and impact on the society. A survey by the World Health 
Organization (WHO) in 14 countries concluded that prolonged pain (present most of the time 
for a period of 6 months or more during the prior year) has prevalence rates between 5,5% and 
33% and a combined result of 21,5% (Gureje et al., 1998; Bond et al., 2006). Chronic pain is 
triggered by injury or disease but may be perpetuated by factors other than the initial cause 
and therefore to outlast it (Loeser and Melzack, 1999). According to the nature of the 
underlying cause it can be classified as nociceptive, inflammatory or neuropathic according to 
the underlying cause (Ashburn and Staats, 1999), although in some cases a clear 
classification cannot be attained as the triggering factors may be multiple (e.g. complex 
regional pain syndrome (CRPS); Baron et al., 2010). 
 
Neuropathic pain is defined by the International Association for the Study of Pain (IASP) as a 
pain initiated or caused by a primary lesion or dysfunction in the nervous system (Merskey and 
Bogduk, 1994, 1997). The Neuropathic Pain Special Interest Group (NeuPSIG) of the IASP 
has, however, recently proposed a new definition: pain arising as a direct consequence of a 
lesion or disease affecting the somatosensory system (Treede et al., 2008; Jensen et al., 
2011). The replacement of dysfunction by disease accounts for the fact that the former also 
included pain caused by neuroplastic changes as a result of intense stimulation and therefore 
not necessarily neuropathic. Additionally, nervous system is replaced by somatosensory 
system, excluding this way, for instance, pain associated with muscular spasticity resulting 
from lesions in the central motor pathways (Hansson, 2010; Haanpaa et al., 2011). 
Neuropathic pains encompass a number of heterogeneous conditions (table I) with diverse 
aetiologies and anatomical locations ranging from the peripheral nociceptor to higher centers 
in the brain (Dworkin et al., 2003; Dworkin et al., 2007; Jensen and Finnerup, 2007). Despite 
the diversity of presentations, several common features can nevertheless be identified. These 
include concomitant partial or total loss of sensation (anesthesia) and pain in the same defined 
anatomical area, ongoing, paroxysmal or evoked pain, after sensations, abnormal summation 
and autonomic features (Dworkin et al., 2003; Jensen and Finnerup, 2007; Hansson, 2010). 
Negative signs reflecting nervous system damage like partial or complete sensory loss and 
positive signs like allodynia, hyperalgesia, dysesthesia and hyperpathia, which reflect 
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hiperexcitability, can coexist simultaneously (Woolf and Mannion, 1999; Jensen and Finnerup, 
2007; Bouhassira and Attal, 2011) and in diverse combinations (Maier et al., 2010). 
 
Table I. Common types of neuropathic pain (Dworkin et al., 2003) 
Peripheral 
Acute and chronic inflammatory demyelinating polyradiculoneuropathy   
Alcoholic polyneuropathy 
Complex regional pain syndrome 
Entrapment neuropathies (e.g. carpal tunnel syndrome) 
HIV sensory neuropathy 
Iatrogenic neuralgias (e.g. post mastectomy or post thoracotomy) 
Idiopathic sensory neuropathy 
Nerve compression or infiltration by tumour 
Nutritional deficiency-related neuropathies 
Painful diabetic neuropathy 
Phantom limb pain 
Postherpetic neuralgia 
Postradiation plexopathy 
Radiculopathy (cervical, thoracic or lumbosacral) 
Toxic exposure-related neuropathies 
Trigeminal neuralgia 
Posttraumatic neuralgias 
Central  
Compressive myelopathy from spinal stenosis 
HIV myelopathy 
Multiple sclerosis-related pain 
Postischemic myelopathy 
Postradiation myelopathy 
Poststroke pain 
Posttraumatic spinal cord injury pain 
Syringomyelia 
 
 
1.3.1. Animal models of chronic neuropathic pain 
 
Animal models of neuropathic pain have been proven to be valuable tools in the research of 
pain mechanisms. The clinical conditions leading to neuropathic pain present a high degree of 
variation (table I) implying therefore that the pathophysiological mechanisms need different 
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modelling. This is reflected in the significant number of animal models of chronic neuropathic 
pain  that  have  been  developed  in  the past decades (see table II; Bennett, 1993; Kim et al.,  
 
Table II. Animal models of chronic neuropathic pain 
Model Key references 
Complete sciatic nerve transection Wall et al., 1979b 
Chronic nerve (sciatic) compression Mackinnon et al., 1984 (rat); 1985 (primate) 
Chronic sciatic constriction injury (CCI) Bennett and Xie, 1988; Grace et al., 2010 (graded) 
Partial sciatic nerve ligation (PSNL) Seltzer et al., 1990; Malmberg and Basbaum, 1998 
(mouse); Hulse et al., 2008 (mouse; saphenous) 
Spinal nerve ligation (SNL) Kim and Chung, 1992 (rat, L5/6); Carlton et al., 1994 
(primate, L7) 
Sciatic cryoneurolysis DeLeo et al., 1994 
Experimental lumbar radiculopathy Kawakami et al., 1994 
Inferior caudal trunk injury Na et al., 1994 
Trigeminal neuralgia (infraorbital nerve) Vos et al., 1994 CCI; An et al., 2011 (cobra venom) 
Toxic exposure-related neuropathies Aley et al., 1996 (vincristine); Authier et al., 2003 
(cisplatin); Authier et al., 2009 (various); 
Photochemically-induced ischemia of the sciatic Gazelius et al., 1996 
Models of inherited neuropathies Martini, 1997; Meyer Zu Horste and Nave, 2006 
Sciatic nerve neuritis Eliav et al., 1999 
Viral-related neuropathies  Fleetwood-Walker et al., 1999 (Chronic varicella-zoster 
virus infection); Wallace et al., 2007 (human 
immunodeficiency virus type 1 glycoprotein 120) 
Spared nerve injury (SNI) Decosterd and Woolf, 2000; Lee et al., 2000 
Partial sciatic nerve transection Lindenlaub and Sommer, 2000 
Sciatic inflammatory neuritis  Chacur et al., 2001 
Malignant sciatic neuropathy Shimoyama et al., 2002 
Nonarteritic anterior ischemic optic neuropathy Bernstein et al., 2003 (rat); Chen et al., 2008 (primate) 
Avulsion of the brachial plexus Rodrigues-Filho et al., 2003 
Diabetic sensory neuropathy models Calcutt, 2004 
Chronic post-ischemia pain (hindpaw) Coderre et al., 2004 
Common peroneal nerve ligation Vadakkan et al., 2005 
Saphenous partial ligation Walczak et al., 2005 
Spinal nerve transection  Hasnie et al., 2007 
Sciatic nerve cuffing Benbouzid et al., 2008; 
Auditory neuropathy Matsumoto et al., 2008 
Thalamic syndrome Wasserman and Koeberle, 2009 
Spinal cord injuries Nakae et al., 2011 
Optic nerve crush Tang et al., 2011 
Autoimmune (antibody-mediated) neuropathy models Willison, 2011 
Partial injury of the median and ulnar nerves Yi et al., 2011 
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1997; Bennett et al., 2003; Wang and Wang, 2003; Dowdall et al., 2005; Authier et al., 2009; 
Decosterd and Berta, 2009; Jarvis and Boyce-Rustay, 2009; Klusakova and Dubovy, 2009; 
Bennett, 2010; Colleoni and Sacerdote, 2010; Khan and Hargreaves, 2010; Jaggi et al., 2011; 
Nakae et al., 2011). The first model of peripheral neuropathy consisted in the complete 
denervation of the distal limb simulating a condition of anesthesia dolorosa (Wall et al., 1979a; 
Wall et al., 1979b). Self-mutilation of the deafferented areas (autotomy) was used as an index 
of pain as evoked responses could not be obtained in the affected areas (Wall et al., 1979a; 
Kauppila, 1998). Models subsequently developed involved in its majority traumatic injury of 
peripheral nerves, nerve roots or spinal cord, caused by sectioning, cuffing, ligation, freezing, 
inflammation and/or ischemia (Decosterd and Berta, 2009; Mogil, 2009). Additionally, drug 
toxicity and systemic metabolic disorders have also been used to trigger neuropathies. Some of 
the most common used models of chronic neuropathic pain are presented in table II.  
 
 
1.3.2. Central plasticity in chronic pain states 
 
In the above citation of the seminal work Gunshot Wounds and Other Injuries of the Nerves 
(Mitchell et al., 1864) published close to the end of the American Civil War (1861-1865), Silas 
Wier Mitchell and colleagues described for the first time some peculiar characteristics of a pain 
syndrome later named causalgia, observed in young soldiers that had been hit by projectiles. 
These included a (i) temporal mismatch between the initial injury and the pain onset, (ii) the 
persistence of pain long after the healing of the primordial injury, (iii) a drop in the pain 
threshold and (iv) a paradoxal manifestation of pain in unaffected dermatomes. A role of the 
central nervous system in this and other painful conditions was largely disregarded for more 
than one century, except for two works that postulated its influence on the amplification of 
ischemic cardiac pain (Sturge, 1883) and on the manifestation of secondary hyperalgesia in an 
experimental pain study in human volunteers (Hardy et al., 1950). The breakthrough discovery 
came in 1983 in a series of electrophysiological studies of the responses of spinal cord flexor 
motoneurons to peripheral stimulation (Woolf, 1983). Central sensitization, as the described 
phenomenon became known, provides a rational framework for the temporal, spatial and 
threshold alterations like those observed by Mitchell more than one century before 
(Latremoliere and Woolf, 2009). The biological importance of central (and also peripheral) 
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sensitization can be ascertained by its conservation across virtually all animal phyla (Woolf and 
Walters, 1991; Walters, 2009). In normal conditions, central sensitization has a benign 
character, as it lowers pain thresholds in injured tissues and surrounding areas, favouring 
protective behaviours. However, in pathological conditions involving sustained inflammation 
and lesions to the nervous system, the benign character is lost, and pain serves no protective 
and/or biologically relevant role. This form of centrally established plasticity decouples the 
peripheral stimulus from its regular central processing to a point that pain no longer reflects 
the existence of a peripheral noxious event but solely a new organization of the central circuitry 
(Woolf, 2011). 
 
Peripheral and central sensitization differ in many respects both at the mechanistic level as 
well as in their manifestations (Latremoliere and Woolf, 2009). Perl and colleagues (1976) 
were the first to describe that nociceptor peripheral terminals can become sensitised following 
injury. This phenomenon was then observed by others in different conditions (Meyer and 
Campbell, 1981; LaMotte et al., 1982; LaMotte et al., 1983; Torebjork et al., 1984; Kocher et 
al., 1987; Campbell et al., 1988a; Bishop et al., 2010). Peripheral sensitisation manifests as a 
drop in threshold and consequent amplification of nociceptors response when these are 
exposed to damaged tissue and inflammatory mediators. This form of sensitization depends on 
nociceptor activation at the periphery, the effect being therefore restricted to the affected area 
and is the core mechanism underlying heat primary hyperalgesia (Hucho and Levine, 2007; 
Latremoliere and Woolf, 2009; Ringkamp and Meyer, 2009). On the contrary, manifestations 
of central sensitization can disperse to areas unrelated with the primary injury as in the cases 
described by Mitchel (Woolf, 2011). Mechanical allodynia is one of such manifestations. In this 
case, inputs that normally parallel the nociceptive pathway, including low-threshold 
mechanoreceptors, are co-opted, resulting in Aβ fiber-mediated pain (Woolf and Salter, 2000). 
In fact, blood-brain barrier impermeable lidocaine analogues, contrary to regular lidocaine, fail 
to abolish mechanical allodynia when injected systemically evidencing its central mediation 
(Chen et al., 2004).  
 
The cascade of events that follow peripheral nerve lesion (or sustained inflammation) and 
eventually leads to central sensitization can be summarized as follows (Saade and Jabbur, 
2008): 1. spontaneous activity is generated (Wall and Gutnick, 1974; Devor, 2009) both in 
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injured and intact fibers (Wu et al., 2001; Lee et al., 2003); 2. locally (and centrally) pro-
inflammatory molecules are released, (Campana et al., 2006; Campana, 2007; Schäfers et 
al., 2007); 3. phenotype switch occurs in the form of expression of new receptors and ionic 
channels giving the nociceptor a sensitised profile (Waxman, 1999) and, additionally, an 
otherwise “silent” or “sleeping” C-fiber population is recruited (Schmidt et al., 1995); 4. 
peripheral and central fibers reorganize (McMahon and Kett-White, 1991; Woolf et al., 1995); 
5. receptive fields and sensory modalities of both injured and intact fibers modify as a 
consequence (Campbell et al., 1988b; Gracely et al., 1992; Liu et al., 2000; Pitcher and 
Henry, 2004). The resulting augmented afferent barrage to the spinal cord drives central 
sensitization (Latremoliere and Woolf, 2009; Ossipov and Porreca, 2009). In fact, 
pharmacological block of the afferent activity prevents the development of behavioural pain 
symptoms (Xie et al., 2005). Additionally, descending facilitation from the brain also 
contributes to central sensitization at spinal cord level (Heinricher et al., 2009; Ossipov and 
Porreca, 2009). The RVM has been the most studied in this context. The surgical interruption 
of RVM-spinal cord communication (Ossipov et al., 2000; Burgess et al., 2002; Gardell et al., 
2003), its pharmacological inactivation with lidocaine (Pertovaara et al., 1996; Burgess et al., 
2002) or the selective ablation of µ-opiod receptor positive RVM neurons (Porreca et al., 2001; 
Burgess et al., 2002; Gardell et al., 2003) abolished behavioural signs of ongoing pain 
(Ossipov and Porreca, 2009). This is not an exclusive action of the RVM as other areas, 
namely the medullary pronociceptive dorsal reticular nucleus (DRt) (Almeida et al., 1996; 
Almeida et al., 1999; Lima and Almeida, 2002) were also shown to contribute to sensitization 
(Sotgiu et al., 2008).  
 
Central sensitization is the consequence of a number of functional, chemical, and structural 
plastic alterations. These are extensively characterized in the spinal cord and, to certain extent, 
in the brain (Saade and Jabbur, 2008; Zhuo, 2008; Jaggi and Singh, 2011). Similarly to what 
is observed in the spinal cord in different animal models of chronic pain, signs of abnormal 
neuronal activity have been recorded in the brain, namely in the RVM (Goncalves et al., 2007), 
thalamus (Guilbaud et al., 1990; Miki et al., 2000), Amy (Ikeda et al., 2007) and prefrontal 
cortex (PFC; Zhuo, 2008). Measurements of metabolic activity anatomically correlate with 
electrophysiological data (Mao et al., 1993; Neto et al., 1999) and, again, in notable parallel 
with similar observations in the spinal cord (Schadrack et al., 1999). Data from brain imaging 
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studies in human patients with chronic pain support an increased activity in the PFC but, 
paradoxically, not in the thalamus (Seifert and Maihofner, 2009; Apkarian, 2010). At the 
morphological level, structural abnormalities have been reported both in animal (Seminowicz et 
al., 2009; Millecamps et al., 2010) and human studies (May, 2008). Generally, these reflect a 
decreased gray matter density and have been detected in brainstem, thalamus, PFC and 
somatosensory cortex. On the contrary, an increase in the striatum and in the orbitofrontal 
cortex (OFC) gray matter was reported in patients with fibromyalgia (Schmidt-Wilcke et al., 
2007). Alterations in brain neurochemistry have also been observed both in the animal model 
and (Millan, 1999) in the human disease (Grachev et al., 2000). Of particular interest in the 
context of pain, µ-receptor availability was found to be decreased in the Amy, accumbens and 
dorsal cingulate in patients with fibromyalgia (Harris et al., 2007) and in the Amy of mice 
(Narita et al., 2006). Concerning the activation of the glial population, which is a neuropathy 
hallmark in the spinal cord, in the brain findings are contradictory. While some groups report 
an increase of both microglial and astrocytic markers in the brainstem, thalamus and forebrain 
(Raghavendra et al., 2004), others found no alterations (Zhang et al., 2008).  
 
The morphological and functional alterations described above impact not only in areas with an 
established role in pain modulation but also in areas that are classically associated with the 
modulation of emotional and cognitive behaviour, like the Amy and the PFC. In fact, anxiety, 
depression and cognitive impairments are frequent comorbidities associated with human 
chronic pain suggesting a causality relation (Moriarty et al., 2011). Experimental animal 
models, however, have produced contradictory results concerning the emergence of these 
traits. This can largely be attributed to the experimental factors varying among the reports, 
some of these underlying putatively important aspects of the pathophysiology. Yalcin and 
colleagues, for instance, have recently established that the duration of the neuropathy is a 
determinant factor in the expression of emotional alterations, with anxiety-like behaviours 
appearing first, followed then by depressive-like behaviours suggesting that the process has a 
well defined kinetic (Yalcin et al., 2011). Additionally, given the organization of the ascending 
pathways described previously (see 1.2.2.) one might postulate that the left/right origin of pain 
can differentially affect areas that are functionally lateralized like the Amy and the PFC, having 
therefore a selective functional impact. Despite this, left and right neuropathies have been 
indiscriminately used in the published reports. On the contrary, factors like gender and age of 
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experimental subjects are the same in all studies (only young male animals have been used). 
Although being a great advantage for comparison terms, this leaves uncovered important 
aspects of the human pathology. This is particularly pertinent concerning ageing because of 
the increased prevalence of pain, notably pain associated with musculoskeletal degenerative 
conditions, in the elderly (Jones and Macfarlane, 2005). It should, however, be acknowledged 
that the relation is complex and some pain conditions are in fact age-independent (e.g. 
stomach and head) or decrease with age (e.g. abdominal and some types of orofacial pain) 
(Jones and Macfarlane, 2005). The neuropathy prevalence is also positively correlated with 
aging both in humans and in rats (Gagliese and Farrell, 2005) although results concerning with 
its algesic quality are contradictory (Gagliese and Melzack, 1997, 2000; Gagliese and Farrell, 
2005; Gagliese and Melzack, 2005). Importantly, the risk of affective disorders (Vink et al., 
2008; Wolitzky-Taylor et al., 2010) and cognitive deterioration (D'Esposito, 1999; Rosenzweig 
and Barnes, 2003; Jones et al., 2006) is also increased in the aged individual augmenting the 
chances of co-occurrence with pain.  
 
 
1.4. Aims 
 
The general aim of the present thesis was therefore to further extend the characterization of an 
animal model of neuropathic pain beyond its somatosensory disturbances, namely in respect 
to the manifestation of emotional and cognitive disturbances. For the reasons raised above, the 
influence of the experimental subject age at the time of the neuropathy induction (chapter 2.1.) 
and its lateralization (chapter 2.2.) were studied. Concerning the cognitive impact of the 
neuropathy, which is by far less studied than the emotional impact, a diversified battery of 
tests were employed in order to ensure a good characterization of the executive function 
domains affected. Additionally, considering that some of these domains have well established 
anatomical substrates we aimed to gain some insight into the areas of increased susceptibility.  
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Chronic pain syndromes encompass several clinical entities that frequently affect the individuals’
emotional and cognitive behaviours which, in turn, can also alter pain perception. Additionally, both
pain perception and motivational-affective behaviours change with increasing age. In order to evalu-
ate the inﬂuence of age upon the interaction between chronic pain and affective/cognitive behaviours,
3-, 10- and 22-month-old rats with 1 month neuropathy (spared nerve injury, SNI model) were com-
pared with age-matched sham-operated controls in the open ﬁeld (OF; locomotor and exploratory
behaviours), elevated plus-maze (EPM; anxiety-like behaviour), forced swimming (FST; depressive-like
behaviour), working memory water maze (WM; spatial short-term memory), Morris water maze
(MWM; spatial reference memory) and spatial reversal (behavioural ﬂexibility) tests. Locomotor and
exploratory activities decreased steadily with age and were further reduced by SNI. Aging was asso-
ciated with increased anxiety-like behaviour, which was potentiated by SNI in both 3- and 22-month-
old rats. The performance in the FST was affected by SNI but only in mid-aged animals. Cognitive per-
formances in the MWM and spatial reversal tests deteriorated with age; however, the SNI lesion was
only detrimental in the reversal task to mid-aged animals. Our data demonstrate that the inﬂuence of
neuropathic pain on affective and cognitive behaviours is age dependent and varies with the behav-
ioural domain that is tested. Importantly, mid-aged animals seem to be more susceptible to depres-
sion and cognitive deterioration associated to chronic pain than young and old groups.
 2009 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.1. Introduction
Pain is a multidimensional experience with sensory-discrimina-
tive and motivational-affective components [77] and thus variation
in pain sensitivity across life span is not a linear phenomenon
among different people. It depends on pain modality, gender,
pain-related past experiences and the contribution of several
unidentiﬁed factors. Moreover, the construction of solid models
for age dependence of pain sensitivity has been hampered by the
existence of contradictory data (see reviews by [28–30]).
Alterations in the neuronal substrates underlying pain sensa-
tion and in the respective subsidiary glial arrays might in part ex-
plain differences in age-dependent pain behaviour. Reported
alterations include: (i) anatomical and morphological senescence
events [2,7,25,61,79]; (ii) variations in neurotransmitters and
receptors implicated in pain sensation and modulation [6,17,20,or the Study of Pain. Published by
: +351 253 604809.
lmeida).
/neurc/index.htm (A. Almei-21,34,39,45,46,51,59,60,64]; (iii) changes in neuronal electrophys-
iological properties as response latency, intensity, pre- (back-
ground) and post- (after discharges) stimuli activity and
receptive ﬁeld sizes [45,50,84]; and (iv) modiﬁcations in the glial
activation status [90,91] and glia-to-glia coupling [41]. Similarly,
emotional and cognitive behaviours are also sustained by plastic
neuronal structures that display alterations with aging [33,75].
Among others, dysregulation of the hypothalamic–pituitary–adre-
nal (HPA) axis occurs during normal aging in both aged human and
animal subjects [73]. This new hormonal milieu impacts on several
central nervous system areas, notably the hippocampus and the
prefrontal cortex (PFC) at morphological [15,88] and electrophysi-
ological [14,49] levels (see also [13,86]), providing a plausible con-
tribution for augmented anxiety levels, depressive symptoms and
cognitive impairments in aged subjects.
Chronic pain syndromes comprise a vast and heterogeneous
group of clinical entities that are frequently accompanied by debil-
itating mood disorders such as anxiety and depression [58,69]. De-
spite this, there are only a handful of animal studies using models
of prolonged pain to assess the impact of chronic pain on emo-
tional behaviour [35,37,53,66,67,92] and none has analysed theElsevier B.V. All rights reserved.
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report how 1 month of spared nerve injury (SNI) model neuro-
pathic pain [24] affects the behavioural performance of 2
(young)-, 9 (mid-aged)- and 21 (old)- month-old rats in different
emotional and cognitive tasks.
2. Materials and methods
2.1. Animals
Fifty male Wistar-Han rats (Charles River Laboratories, Barce-
lona, Spain) aged, at the beginning of the protocol, 8 weeks (young
animals, n = 21), 9 months (mid-age animals, group n = 18) and
21 months (old animals, n = 11) were used. Weight ranges for
young, mid-aged and old animals were 230–300 g, 500–600 g
and 650–850 g, respectively. Animals were housed in plastic cages
in groups of 2 to 3 with food and water available ad libitum in a
standard vivarium with controlled temperature (22 ± 1 C) and a
12 h light/dark cycle (lights on at 8 a.m.). All experiments were
performed during the light period of the cycle, starting at 9:00
and extending as far as 18:00 depending on the duration of each
protocol (see below). Acclimatization to the testing room was al-
lowed for approximately 1 h. All procedures with animals followed
the normatives stated by the European Community Council Direc-
tive 86/609/EEC and the ethical guidelines for the study of experi-
mental pain in conscious animals [104]. At least one category C
FELASA certiﬁed experimenter (see the Federation of European
Laboratory Animal Science Associations web page http://
www.felasa.eu/ for more information) was present when animals
were manipulated. Detailed information on experimental condi-
tions is given as supplemental material according to the guidelines
established by others [80].
2.2. Surgery and experimental design
An experimental neuropathy was induced using the spared
nerve injury (SNI) model, as originally described by Decosterd
and Woolf [24], in half of the animals of each age category, the
remaining being sham operated and used as controls. Animals
were deeply anaesthetized with a mixture of 1.5: 1.0 of ketamine
(Imalgene)/medetomidine (Dormitor) at a dose of 1 mL/kg. The
hairy skin of the left limb lateral surface was shaved and a longitu-
dinally oriented incision was made. The musculature was blunt
dissected and the sciatic nerve and its three terminal branches,
sural, common peroneal and tibial, were exposed. The last two
branches were then tightly ligated with 4–0 silk ligatures and a
1 mm portion was distally sectioned. Caution was taken not to
damage or stretch the sural nerve, which should remain intact
(spared nerve). Similar procedures were applied to the sham
groups, except that all nerves were exposed but left untouched. Fi-
nally, muscles and skin were separately sutured. During the recov-Fig. 1. Chronogram of the experimental protocol. Eight weeks (young), 9 months (mid-a
controls, were submitted to a battery of daily tests according to the following sequence: O
i.e., the submerged platform (see main text) was located in the same quadrant of the swim
response, a well-known marker of neuropathy in nerve-injury models, using calibrated Vo
ﬁeld; MWM – Morris water maze; WM – working memory.
52ery period animals were left in individual cages for 24 h and then
placed with their previous cage-mates.
During the ﬁrst month after surgery, except for cage cleaning
and non-scheduled occasional handling twice a week, animals
were left without any kind of manipulation, to avoid additional
distress. Then, a battery of behavioural paradigms was employed
as represented in Fig. 1. Animals were always tested in the same
pre-established order, which included testing sequentially sub-
groups of young SNI, young sham, mid-aged SNI, mid-aged sham,
old SNI and old sham animals. Since this sequence was repeated
three times until all animals were tested, the inﬂuence of con-
founders such as the testing hour was equally distributed through
all the experimental groups. A brief summary on each test is given
below (for a recent review see for example [87]).
2.2.1. Open ﬁeld
The open ﬁeld (OF) is probably one of the oldest behavioural
paradigms in rodents (Hall 1934). It is a versatile test that permits
assessment of anxiety-like exploratory and locomotor behaviours
by measuring, respectively, the percentage of time spent in the
centre of the OF arena (higher values being associated with less
anxious proﬁles [78]), the amount of rearing activity and the total
distance travelled [87]. The OF was performed in a square
(43.2 cm  43.2 cm) arena with transparent acrylic walls (Med
Associates Inc., St. Albans, Vermont, USA) placed in a brightly illu-
minated room. Animals started the test at the arena’s centre and
were given 5 min to explore it. Location (peripheral versus central)
and total distance travelled in the arena were automatically regis-
tered by equipment sensors. Additionally, the number and dura-
tion of rearings were manually registered by an observer located
1.5–2.5 m away from the apparatus. The inner areas, ﬂoor and
walls, were cleaned with 10% alcohol and carefully dried between
trials. This test spanned for approximately 6 h, starting at 9 a.m.
2.2.2. Elevated plus-maze
The elevated plus maze (EPM) was developed to test anxio-
lytic/anxiogenic effects of drugs in rodents [36,74] and it is pres-
ently considered the most validated and reliable test of anxiety-
like behaviour. The rationale of the test results from the conﬂict
between the drive to explore the maze and the aversion to open
areas. More anxious behavioural proﬁles are correlated with
smaller ratios between time spent in the open arms and in the
closed arms (open arm avoidance index). Other EPM behavioural
indexes are: (i) risk assessment (RA) (calculated according to the
formula: RA = [number of explorations/(300  open arm time in
seconds)]  60) for exploratory activity and (ii) the number of
entries in EPM closed arms for locomotor activity, which is con-
sidered more valid [9,22,81] than the total (open + closed) num-
ber of arms entries (see [95] and references within). The EPM
was performed in a plus-shaped maze made on black polypro-
pylene plastic, with two opposed open arms (50.8 cm  10.2 cm)ged) and 21 months (old) old animals with 1 month neuropathy and correspondent
F, EPM, FST, WM, MWM and reversal. On the seventh day, WM andMWM coincided,
ming pool. One week after the behavioural tests, animals were probed for allodynic
n Frey ﬁlaments. EPM – elevated plus-maze; FST – forced swimming test; OF – open
Table 1
Sequence and organization of the cognitive tests: working memory (WM), Morris
water maze (MWM) and reversal (see main text for details on each of these tests). The
location of the platform on each day and the starting quadrant in each of the four
trials are referred. When coincident, this was highlighted. In the WM, animals had to
learn a new platform location on a four-trial run, everyday. In the MWM, reference
memory was tested by keeping the platform position unaltered for four consecutive
days during each of which the starting quadrant for each trial was randomly assigned
(order repetitions were not allowed). Finally, on the last day, after a 4-day period
learning a location, behavioural ﬂexibility was tested by changing the platform to a
new position – approximately opposed to the previous – within the north quadrant,
N* (different from that on day 5).
Day Protocol Platform location Starting quadrant
4 WM O N S O E
5 WM N O N S E
6 WM E E S N O
7 WM/MWM S E O N S
8 MWM S N S E O
9 MWM S S N O E
10 MWM S O E S N
11 Reversal N* N S E O
H. Leite-Almeida et al. / PAIN 144 (2009) 57–65 59and two opposed closed arms with the same dimensions but
surrounded by walls (40.6 cm height; Med Associates Inc., St. Al-
bans, Vermont, USA). The whole structure was elevated 72.4 cm
from the ﬂoor and was placed in the centre of same room where
the OF took place the previous day. Each animal was placed at
the centre of the maze and allowed to explore for 5 min. The
number of arm entries, the time spent in each arm and the num-
ber of explorations were automatically recorded. Inter-trial pro-
cedures were as described for the OF. This test spanned for
approximately 6 h, starting at 9 a.m.
2.2.3. Forced swimming test
Since its development in the mid-1970s [76], the forced swim-
ming test (FST) has been employed as a successful screening tool
for assessing antidepressant-like effects of drugs in rodents. The
perseverance of the animal struggling to escape from an inescap-
able aversive scenario (a cylinder full of water), has been proved
to be inversely correlated with a depressive-like proﬁle. Two
parameters are currently employed: 1. latency to immobility (Lati)
– the duration of the ﬁrst and usually most intense period of escap-
ing activity (inverse correlation with depressive states); 2. immo-
bility (Ti) – total time staying aﬂoat without trying to escape
(direct correlation with depressive-like proﬁles). The FST was per-
formed in a cylinder ﬁlled with water (23–24 C) to a depth of
40 cm, such that animals could not lay their rear paws on the bot-
tom without being totally submersed, and with a height of 30 cm
above the water level, thus preventing the escape of the animals.
A ﬁrst trial in the FST (training) was done approximately 1 h after
the EPM after which animals were allowed to rest 24 h before the
second session (test). Both sessions lasted 5 min and were video-
taped by a ﬁxed camera located on the ceiling. Since two different
animals were simultaneously recorded (using two FST equip-
ments), the whole FST session lasted only 3 h, starting at 12 p.m.;
this ensured homogeneity of testing times between all animals.
Lati and Ti parameters from the second (test) trial were scored off-
line using the freeware Etholog software [71].
2.2.4. Cognitive tests
Cognitive tests were made in a black, circular (170 cm diame-
ter) tank, ﬁlled with water (23–24 C) to a depth of 31 cm in a
dimly illuminated room with spatial clues on the walls, kept unal-
tered during the duration of the experiment. A video camera ﬁxed
on the ceiling, above the centre of the tank, captured the image to a
video tracking system (Viewpoint, Champagne au Mont d’Or,
France) located in an adjacent room. Four virtual quadrants [north
(N), east (E), south (S) and west (W)] were then assigned on the
computer and a black circular platform, 12 cm in diameter, 1 cm
below water surface (therefore, invisible to the rats) was placed
within one of the quadrants. The position of the platform varied
according to each test (see below). In each testing, animals were gi-
ven four trials to ﬁnd the platform, each starting from a different
quadrant. At the beginning of each trial, animals were gently
placed in the periphery of the selected quadrant, approximately
half-way from its limits and facing the wall of the maze. Trials
were automatically ended once the animals reached the platform
or 120 s had elapsed, whichever occurred ﬁrst. If an animal failed
to ﬁnd the platform in 120 s, it was gently guided to it and allowed
to remain there for 30 s before starting a new trial. Time to escape
to the platform, as well as to the path, and distance swum during
that period were automatically recorded.
2.2.4.1. Working memory. The working memory (WM) test is a
modiﬁcation [23] of the Morris water maze (MWM [65]). It mea-
sures the ability of the animal to acquire and keep on line during
four consecutive trials, information about the platform location
that is changed daily to a different quadrant (Table 1).2.2.4.2. Morris water maze. The MWM test was designed to study
the animal capacity to learn the platform location during four con-
secutive days – spatial reference memory [65]. The platform was
therefore kept in the same position throughout the test (Table 1).
2.2.4.3. Reversal. The day after learning the platform location in the
MWM, animals were similarly tested during four trials, but with
the platform positioned in the opposite quadrant (Table 1). The
rationale underlying this test is that animals displaying behav-
ioural ﬂexibility will rapidly learn to search the platform in its
new location while impaired rats will spend more time around
the old location.
2.2.5. Von Frey
One week after the end of the emotional and cognitive behav-
ioural tests, animals were evaluated for allodynic responses, a hall-
mark for a neuropathic chronic pain condition. Each paw (ipsi- and
contralateral) was probed with Von Frey ﬁlaments on the lateral
surface (sural nerve territory), starting with softer (lower bending
force) and progressively increasing to harder Von Frey ﬁlaments,
each applied ﬁve consecutive times in each paw. The brisk lifting
of the probed paw was considered a positive pain-like response;
simultaneous similar movements of the other paw – mirror-re-
sponses – were also registered but not considered as a pain re-
sponse. This test was performed on an elevated grid, where the
animals were placed, inside an inverted white light-transparent
plastic box to limit their movements. In order to minimise the po-
tential stressful impact of the testing conditions, animals were al-
lowed to acclimatize daily to the examination room, for 1 week
before the test (Fig. 1).
2.3. Statistical analysis
Results are expressed as means ± standard errors. Comparisons
between means were analysed with one-way or repeated mea-
sures analysis of variance (ANOVA), as appropriate. Differences be-
tween groups were analysed post-hoc with Tukey’s honestly
signiﬁcant differences test (Tukey’s HSD). Results were considered
statistically signiﬁcant if p < 0.05.
3. Results
3.1. General considerations
After the SNI/sham surgery, animals spent 1 month period
without any manipulation besides cage cleaning and occasional53
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this period, animals were monitored for abnormal signs indica-
tive of disease (e.g. weight loss, infections, alterations in groom-
ing and other behaviours). Only one wound infection, promptly
treated with the topical application of chlorohexidin, was de-
tected, in a mid-age SNI animal; as this resolved in less than
1 week, we found no motives for not including the animal.
All SNI rats developed signs of spontaneous pain (ﬂinching and
paw protection) almost immediately after nerve lesion and brisk
pain responses were elicited when forces as low as 0.04 g were ap-
plied to the lateral area of the nerve-lesioned paw. When this paw
was probed ﬁve times with the 1 g Von Frey ﬁlament, nearly 75%,
85% and 60% of young, mid-aged and old SNI animals, respectively,
responded at least once (Fig. 2A). In contrast, only 1 of 11 young
animals and no mid-aged nor old sham animals responded to the
same ﬁlament. After stimulation with a 15 g ﬁlament, virtually
all (100%) SNI animals from all age groups showed pain-like behav-
iour, while only 40% (young) – 60% (old) of sham-operated animals
showed the same type of reaction (Fig. 2B).
3.2. Locomotor behaviour
The total distance travelled in theOF, the number of entries in the
EPM closed arms and the average velocity in the water maze were
used as locomotion indexes (Fig. 3). In the OF, a stepwise decrease
in motor activity was apparent with increasing age (F2,44 = 31.811,
p < 0.001). Nerve lesion also affected locomotor activity signiﬁcantly
(F1,44 = 17.126, p < 0.001), with older animals being more suscepti-
ble to its effects (interaction between age and nerve lesion
F2,44 = 3.606,p = 0.035; Fig. 3A). Speciﬁcally,whenage-matched ani-
mals were compared, SNI animals were found to travel signiﬁcantlyFig. 2. Percentage of responders to 1 g (A) and 15 g (B) Von Frey probes on the
ipsilateral paw. The great number of responders in the SNI group to 1 g ﬁlament
probe – an innocuous stimulus for sham animals – is a clear indication of allodynic
behaviour and neuropathy. For comparison purposes, responses to 15 g probe are
also given. Note that sham group scores are still smaller than those obtained with
1 g probe in SNI animals. Results referring to the contra-lateral paws do not differ
from sham ipsilateral paw probing and were therefore omitted.
Fig. 3. Locomotory behaviour. Three indexes of locomotion were accessed: (A) total
distance travelled in the OF; (B) number of entries in the EPM closed arms; (C)
average velocity in the water maze. Note the aging trend similarities of locomotory
activity across the three indexes. *p < 0.05 and **p < 0.001; comparisons within age-
matched animals are indicated over SNI graph bar and comparisons along aging
within surgery groups, sham and SNI, are indicated over horizontal lines. EPM –
elevated plus-maze; OF – open-ﬁeld.
54less than controls, but only in mid-aged (p = 0.028) and old
(p = 0.030) groups. In the EPM, age (F2,43 = 21.335, p < 0.001), but
not SNI (F1,43 = 2.335, p = 0.134), signiﬁcantly reduced the number
of closed arm entries and this effect was similar in both treatment
groups (F2,43 = 2.054, p = 0.141) (Fig. 3B). Mid-aged and old animals
displayed fewer entries in the closed armswhen compared to young
animals of the same experimental group (sham: x mid-aged
p = 0.045; x old p = 0.034; SNI: x mid-aged and x old p < 0.001).
Although it did not reach statistical signiﬁcance, treatment effect
wasmore pronounced in old animals (p = 0.064). In thewatermaze,
age (F2,44 = 4.976, p = 0.011) and SNI (F1,44 = 14.424, p < 0.01) signif-
icantly decreased the average velocity but no interaction was found
between these two factors (F2,44 = 0.272, p = 0.763) (Fig. 3C): nerve
injury decreased the average swimming speed only in mid-aged
and old animals (young p = 0.066; mid-aged p = 0.032; old
p = 0.014).
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The percentage of time spent in the EPM open arms (percentage
of OA; Fig. 4A), and the RA parameter (EPM; Fig. 4B) were used as
anxiety-like behavioural indexes. The total amount of time spent
rearing (Trea; Fig. 4C) and the absolute number of rearings (Nrea;
Fig. 4D) that animals performed during the exploration of the OF
arena were used as indexes of exploratory behaviour.
In the EPM, both percentage of OA (Fig. 4A) and RA (Fig. 4B) sig-
niﬁcantly decreased with increasing age (F2,43 = 15.107, p < 0.001
and F2,43 = 28.922, p < 0.001, respectively) and nerve lesion
(F1,43 = 6.287, p = 0.016 and F1,43 = 4.729, p = 0.035, respectively).
Young SNI and sham animals differed in percentage of OA
(p = 0.028) and RA (p = 0.041) whereas in old animals treatment
affected only percentage of OA (p = 0.016) (Fig. 4A and B). In the
OF, the duration (Trea; Fig. 4C) and the absolute number of rearings
(Nrea; Fig. 4D) inside the OF arena were affected similarly by both
age (Trea F2,44 = 7.725, p < 0.001; Nrea F2,44 = 15.669, p = 0.001) and
surgery (Trea F1,44 = 25.678, p < 0.001; Nrea F1,44 = 20.158, p < 0.001).
Within groups of age-matched animals, Trea andNreawere decreased
by SNI surgery (young pTrea = 0.003 and pNrea = 0.006; mid-aged
pTrea = 0.006 and pNrea = 0.145; old pTrea = 0.020 and pNrea = 0.005).
Additionally, a clear age-dependent attenuation of the exploratory
behaviourwasdetected in the Trea (SNIyoungxmidp = 0.024; SNIyoungxold
p = 0.003) and Nrea (SNIyoungxold p = 0.001; shamyoungxmid p = 0.005;
shamyoungxold p = 0.010) (Fig. 4C and D).
3.4. Depressive-like behaviour
The period of escaping activity between the introduction of the
animal in the water cylinder and the ﬁrst immobilization –Fig. 4. Anxiety-like and exploratory behaviours. Two indexes of anxiety-like behaviour
arms (A) and in the central area of the OF arena (C). The remaining – risk assessment beha
behaviour. *p < 0.05; **p < 0.001; comparisons within age-matched animals are indicated
SNI, are indicated over an horizontal line. EPM – elevated plus-maze; OF – open-ﬁeld.latency to immobilization (Lati; Fig. 5A) – and the amount of time
that the animal stayed aﬂoat without evident efforts to escape –
immobility time (Ti; Fig. 5B), were used as indexes of depressive-
like behaviour. Both factors were signiﬁcantly affected by age
(F2,43 = 4.593, p = 0.016 and F2,43 = 12.376, p < 0.001, respectively)
but not by nerve ligation. Additionally, there was a signiﬁcant
interaction between age and surgery for Ti (F2,43 = 3.747,
p = 0.032). Ti was reduced in mid-aged sham animals compared
to young (p = 0.001) and old controls (p = 0.001). Interestingly,
only in this age group did SNI increase Ti when compared to sham
animals (p = 0.032), indicating a depressive-like behaviour in-
duced by nerve lesion.
3.5. Cognitive assessment
Repeated measures analysis of WM performance demon-
strated only a marginal effect of age (F2,43 = 3.155, p = 0.053)
but not surgery (F1,43 = 3.507, p = 0.068) nor an interaction be-
tween these two factors (F2,43 = 0.662, p = 0.521; Fig. 6A–C). None
of these factors inﬂuenced the performance in the Morris water
maze (Fig. 6D–F). Analyses of behavioural ﬂexibility revealed an
interaction between aging and lesion (F4,86 = 2.630, p = 0.040),
with SNI impairing this behaviour only in mid-aged animals as
revealed by the higher percentage of distance swum in the old
location and lower percentage of distance swum in the new
location of the platform (Fig. 6G). There was, in addition, an
aging effect (F2,43 = 5.108, p = 0.010) with older animals display-
ing a higher percentage of distance swum in the old location
compared to young animals (p = 0.030). No differences were ob-
served in the distances swum in the neutral quadrants (data not
shown).are given, namely the percentage (%) of time spent by the animals in the EPM open
viour (B), rearing time (D) and number of rearings (E) – are measures of exploratory
over SNI graph bars and comparisons along aging within surgery groups, sham and
55
Fig. 5. Forced swimming test for depressive-like behaviour. Two indexes are given:
latency to immobility (A) and immobility time (B). *p < 0.05; comparisons within
age-matched animals are indicated over SNI graph bar and comparisons along aging
within surgery groups, sham and SNI, are indicated over horizontal lines. FST –
forced swimming test.
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In this study we attempt for the ﬁrst time to analyse the com-
bined inﬂuence of aging and chronic neuropathic pain on cognitive
and emotional behaviours in rats. One month after the induction of
SNI, young, mid-aged and old animals went through a battery of
tests and were then probed for signs of allodynia, a well-estab-
lished marker of neuropathic pain. Our results demonstrate that
even nearly 2 months after surgery, animals submitted to SNI dis-
played an increased response to light (1 g) Von Frey probing; per-
sistence of pain related behaviours is a well-known feature of the
SNI model [24]. Spontaneous pain-related behaviours such as
ﬂinching and protection of the affected paw have also been ob-
served in SNI animals during their normal activities in the cages,
possibly indicating ongoing pain. We demonstrate that after
1 month of peripheral nerve injury (SNI model) mid-aged rats,
but not young nor aged animals, acquire a depressive-like behav-
iour and show impairment of executive function (behavioural
ﬂexibility).
4.1. Neuropathic pain increases locomotor impairment with aging
The present study shows that SNI potentiates the reduction of
locomotor activity that normally occurs with increasing age. The
age-related decline in motor performance is in accordance with
previous studies [3,11,12,27,38,44,66,89,97]. The underlying
mechanisms for this phenomenon include a contribution of age-re-
lated alterations of neuronal networks involved in motor activity
(planning, execution and coordination) but also side factors such
as weight gain, diminished metabolic activity as a result of cardio-
vascular and musculoskeletal impairments [3]. Our data also show
that nerve lesion related-impairments of locomotor behaviour aug-
ment with increasing age. A possible explanation might be that
young animals are able to use intact limbs more effectively to over-56come the partial loss of function of the lesioned limb. A more effec-
tive functional recovery in younger animals could also provide an
explanation for the near absence of functional impact of SNI
30 days after the surgery. On the contrary, the locomotor behav-
iour in mid-aged and old animals was reduced after the lesion.
It is not known to what extent performances in movement-depen-
dent behavioural tests such as the OF, EPM and FST are affected but
principal component analyses studies demonstrated an extensive
segregation between motor and anxiety-related indexes in the
EPM [9,22,81] and OF [9]; as expected, the use of anxiolytic and/
or anxiogenic drugs (in a certain dose range) only affected the anx-
iety-related factor [22]. Similar ﬁndings have been reported
recently by Rice’s group in a model of HIV anti-retroviral-associ-
ated pain [96]. Treated and control animals differed in their
thigmotaxic behaviour in OF, the former group presenting a more
anxious-like behaviour, but no differences were found regarding
motor activity. Pharmacological approach with analgesics (gaba-
pentin and morphine) and one anxiolytic (diazepam) drug signiﬁ-
cantly reduced anxious-related behaviour without any
interference with motor behaviour [96] (see also [82]). Concerning
the FST, this test is mostly dependent on forepaws and tail move-
ments and therefore SNI is not expected to interfere extensively:
indeed, intact and operated old animals presented no differences
in this test.
4.2. Neuropathic pain affects behavioural ﬂexibility only in mid-aged
animals
To avoid possible interferences related to altered locomotion
abilities in the water maze tests, we used swum distances (more
related to animals’ strategy) instead of velocities (related to loco-
motive performance) to compare animals’ performances. The
learning curves in the spatial reference memory obtained herein
revealed that aged animals have learning/memory deﬁcits; this is
in accordance with several previous studies [31,32,98]. On the con-
trary, no association between aging and decreased performance
was apparent in theWM test. Nevertheless, it should be noted that,
by the end of both WM and MWM tests, sham and SNI animals
were equally good performers indicating that the memory perfor-
mance was not affected by chronic neuropathic pain. In the rever-
sal task age-related deﬁcits in behavioural ﬂexibility are
demonstrated, as old sham animals failed to show an adaptive
behaviour when challenged with a new rule. Furthermore, in this
test, SNI affected exclusively the performance of mid-aged animals,
with sham rats displaying successful behavioural adaptation (sim-
ilar to young sham and SNI animals) and injured animals failing to
adapt their behaviour (similar to old sham and SNI animals). The
herein reported selectivity of SNI effects for mid-aged rats in the
reversal test is in accordance with the report by Smith and collab-
orators [85] showing that repeated tail pinch only activated the
PFC of mid-aged rats but not of young or old rats. Indeed, behav-
ioural ﬂexibility is associated with the function of the medial PFC
[18,83] and impairments on reversal-type tasks, such as the one
used in the present study, have been associated with volumetric
decreases, neuronal loss, altered dendritic morphologies and im-
paired LTP on the hippocampal-PFC connection [14–16]. It is
remarkable that, in mid-aged rats, SNI seemed to induce a prema-
ture aging of PFC function, suggesting that, in this particular region,
chronic neuropathic pain might trigger, and hasten, the plastic
mechanisms involved in aging. Interestingly, previous studies on
chronic pain subjects (human and animal) have identiﬁed altera-
tions in regional cerebral blood ﬂow [40,72], metabolic neural
activity [62], gray matter density [5,54], gene expression patterns
[4,68], receptor afﬁnity/availability [48], synaptic activity [99]
and glial status [55,67] in prefrontal areas. Moreover, manipulation
of the PFC was shown to alter the nociceptive response in several
Fig. 6. Cognitive behaviours. Animals were challenged with three tasks that differed in their cognitive requirements (see main text for detailed explanation). Working
memory performances of sham and SNI are compared for young (A), mid-aged (B) and old (C) animals. Similarly, Morris water maze (MWM) performances are plotted in
graphs (D)–(F). Reversal task performances are plotted in graph (G). The four quadrants of the pool are assigned with letters W, N, E, S; the actual and the former platform
positions are, respectively, W and E. *p < 0.05; comparisons within age-matched animals are indicated over bar lines. MWM – Morris water maze; WM – working memory.
H. Leite-Almeida et al. / PAIN 144 (2009) 57–65 63models of acute and chronic pain [1,10,19,26,47,56,57,70,101–
103]. Altogether, these studies indicate that the PFC is a likely tar-
get for the mediation of the interaction between cognition and pain
processing. The fact that performances in the MWM and WM are
not affected by the SNI lesion, suggest that the hippocampal func-
tion is preserved after chronic neuropathic pain. This ﬁnding con-
trasts with the report that hippocampal long-term potentiation is
depressed in neuropathic mice [52]. The use of distinct species
and temporal differences in the neuropathy duration (7–9 days in
the later study and over 1 month in the present study) hindered
further comparisons.
4.3. Neuropathic pain affects emotional behaviours differently with
aging
In the FST, mid-aged animals struggled for longer periods of
time and spent signiﬁcantly more time swimming than young
and old animals (similar results were obtained in female mice
[100]). Remarkably, once again differences between sham and
SNI animals were only evident in mid-aged animals; rats submit-ted to SNI presented increased learned helplessness. A number of
functions have been proved to be dependent on PFC activity
including the regulation of emotional behaviour [13]. Whether
these behavioural proﬁles observed in SNI mid-aged animals share
a common neural substrate namely on the PFC, remains to be
proved. However, as stated above, several structural and functional
aspects of PFC have been shown to be dramatically affected by pro-
longed pain.
In this perspective, our data on anxiety-like behaviour appear to
be paradoxical as mid-aged SNI animals are apparently spared
from the anxiogenic effect of the lesion, a well-known phenome-
non in young rodents [63,66,67,92]. Plastic alterations in other
brain centres such as the extended amygdala (AMY) are likely to
be involved. Indeed, afﬁnity shifts of opioidergic ligands, increased
glucocorticoid receptor and corticotropin-releasing factor mRNA
expression, synaptic potentiation, astrogliosis and neurogenesis
in the AMY [35,42,67,94] have been described after peripheral
nerve injury. Concerning the observed age-related anxiogenic ef-
fects in rodents, they are in accordance with previous reports
either using the EPM [8,43], the OF [93] or using both [9].57
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In the present work we demonstrate that some of the cardinal
features of aging are anticipated by peripheral nerve injury. The
near absence of SNI-evoked behavioural effects in old animals in
some of the tasks is possibly due to the poor level of performance
of these subjects in basal (sham) conditions – ‘‘ceiling effect” – pos-
sibly rendering our analyses ineffective to discriminate SNI effects.
On the other hand, behavioural impairments caused by SNI were
evident in mid-aged animals. A putatively higher algesic quality
of mid-life neuropathies has been described (reviewed by [29]),
but at the moment it is premature to establish a causality relation
between these two observations. It also stems from our work that
PFC function appears to be more susceptible to the effects of the
neuropathic lesion than the hippocampal function. This observa-
tion concurs with a vast number of literature published by other
authors and mentioned above, conﬁrming the PFC as one of the
principal targets for future studies.
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The prefrontal cortex is severely affected in prolonged pain conditions. Since it is 
functionally lateralized, we reasoned that its functions could be selectively affected according to 
the side of pain origin. We tested this assumption in rats with a unilateral neuropathy to 
conclude that left-sided neuropathic pain is more anxiogenic than right-sided pain and that the 
latter disrupts efficient executive function and working memory while having no emotional 
effect. 
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Emotional disturbances and cognitive impairments are a common feature of 
prolonged pain conditions1. One of the brain areas most consistently shown to be selectively 
damaged in patients with chronic pain syndromes is the prefrontal cortex (PFC)2,3. Importantly, 
this region is involved in the expression of emotions4 and in a wide range of cognitive 
functions5, therefore appearing as a good candidate for mediating the above mentioned effects.  
The PFC has a central role in working memory, attention, impulsivity and in the 
construction of flexible adaptive behaviors5, collectively named executive functions. Additionally, 
PFC regions were also shown to modulate the expression of emotional states, including 
anxiety, through their projections to centers such as the bed nucleus of stria terminalis, the 
amygdala and the hypothalamus5. The extensive range of cortical and subcortical PFC targets, 
upon which it exerts a top-down control, is matched by a similar broad range of afferents from 
several cortical and subcortical regions6, including direct projections from the spinal cord7. 
Importantly, the PFC is the only cortical area that receives such projections, which might 
explain its selective vulnerability to the effects of prolonged pain. In fact, it has been shown that 
the thalamus, which also receives spinal cord projections, is similarly affected upon prolonged 
pain2. 
If the plasticity observed in cortical and subcortical areas in chronic pain conditions 
relates totally or partially with a disturbance of the ascending pathways we can postulate that 
lateralized pain would have a differential behavioral impact according to its left/right origin as 
the PFC itself has been shown to be functionally lateralized8. 
To test this hypothesis, we assessed the behavior of young Wistar-Han rats after 1 
month of either left- or right-sided neuropathic pain (spared nerve injury model9, SNI) on a 
battery of tests for sensory, emotional and cognitive function. Both right and left sham-operated 
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animals were used as controls but their performances were clustered together since there 
were no differences between them. 
Using established paradigms to assess both acute evoked nociception (von Frey 
monofilaments) and ongoing, non-provoked, pain (analgesia-derived conditioned place-
preference)10 we firstly showed that left- (SNI-L) and right-sided (SNI-R) neuropathies have 
similar algogenic properties. Nerve-injured animals showed an expected decrease of the 
monofilament-induced limb withdrawal threshold, which was of similar magnitude irrespective 
of lesion side (Fig. 1a).  In both left- and right-sided lesion groups (Fig. 1b), but not in sham-
operated animals (Supplementary Figure S1b), a single intrathecal clonidine injection produced 
a significant place-preference for the clonidine-paired chamber. Since increased anxiety is 
frequently reported in both humans with prolonged pain conditions and animal models of 
chronic pain, we assessed anxiety-like behavior, in a different cohort of animals, by exposing 
them for 5 minutes to the elevated-plus maze (EPM). Here, contrary to the previous results, we 
had a lateralized effect of prolonged pain exposure, with SNI-L animals spending significantly 
less time in the open arms when compared to both SNI-R and sham-lesioned animals (Fig. 1c). 
These differences do not relate to alterations in locomotor activity, since the number of closed 
arms entries is similar in all groups (Supplementary figure 2), suggesting therefore an 
increased anxiety-like behavior upon left- but not right-sided chronic pain.   
Finally, to test whether the cognitive effects of prolonged pain were also lateralized, 
we assessed animals for several PFC-dependent executive functions including working memory 
(WM; assessed in the water maze), behavioral flexibility (assessed in an attentional-set shifting 
task; ASST) and impulse control (assessed in a delay-to-signal task; see Supplementary 
Methods for a detailed description). Interestingly, right-lesioned animals showed consistent 
impairments in all tasks, when compared to SNI-L and control rats (respectively Fig. 1d, e and 
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f). Importantly, no significant differences between any experimental groups were observed in a 
hippocampal-dependent spatial long-term memory task (the Morris Water Maze; MWM, 
supplementary Figure 3), suggesting a specific susceptibility of PFC-dependent cognitive 
domains in chronic pain conditions. 
Rodent models of neuropathic pain proved to be robust enough to manifest a whole 
range of emotional and cognitive disturbances observed in human disease besides sensorial 
abnormalities (e.g. hyperalgesia and allodynia) that are considered to be hallmarks of 
neuropathies1,11. Given the well established association between prolonged pain conditions and 
increased anxiety, our findings that only left-lesioned rats do display a hyperanxious phenotype 
are striking, though in line with a previous study in human volunteers12. Concerning the 
detrimental effect of right-sided pain on cognitive function, no parallel exists in the current 
literature.  
Results from our cognitive studies confirm a selective PFC susceptibility in chronic 
pain conditions as SNI-R had deteriorated cognitive performances specifically in PFC-
dependent tasks (WM, ASST and impulse control) but not in the hippocampal-dependent task 
(MWM; supplemental fig. 3), in which performance was at the level of SNI-L and controls. 
Additionally, the fact that SNI-R behavioral performance in the ASST task was only impaired in 
the reversal steps (Rev) but not in the extradimensional shift step (EDS; supplemental fig. 4) 
suggests that PFC malfunction is restricted to the ventral mPFC/OFC subareas, sparing 
dorsomedial prelimbic and cingulate PFC subareas13.  
Apart from cognitive function, manipulations of ventral mPFC/OFC subareas have 
been shown to influence behavioral outcomes in anxiety paradigms and the levels of anxiety–
related biomarkers such as corticosteroids. Importantly, this effect is lateralized, depending on 
the right PFC, expectably the area affected in SNI-L (reviewed by Sullivan and Gratton4). On the 
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contrary, the individual contribution of left/right mPFC to cognitive construction is still a matter 
of debate8. However, Luerding and colleagues found in fibromyalgia patients an impairment on 
non-verbal working memory that was positively correlated with the grey matter volume of the 
left middle frontal gyrus14, expectedly, and according to our guiding hypothesis, the area 
affected in SNI-R animals. 
Curiously, the ventral mPFC and OFC are the only cortical areas where direct 
projections from the contralateral spinal cord dorsal horn terminate (reviewed by Lima7). This 
body of evidence supports our hypothesis that peripheral nerve injury affects the ascending 
pathways resulting in functional impairment of these cortical terminal areas. Given the above 
mentioned lateralization of PFC functioning, particularly in the ventral mPFC and OFC, 
peripheral nerve injury has a differential and selective emotional/cognitive impact according to 
the side of injury.  
In summary, in the present work we demonstrated for the first time that the side of a 
neuropathic lesion is crucial in determining the emotional and cognitive comorbidities 
chaperoning pain.  
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Figure 1. Left- and right-sided neuropathies are detrimental to emotional and cognitive 
behaviors, respectively. (a) Nerve injury produced a significant decrease in the monofilament-
induced limb withdrawal threshold (F2,13=25.98, P<0.0001), while the side of nerve injury had 
no significant effect on the withdrawal threshold. (b) Clonidine treatment (10 µL intrathecally) 
produced a significant place preference for the clonidine-paired chamber (F1,16=26.84, 
P<0.0001), while the side of nerve injury (left versus right) had no influence on the clonidine-
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induced place preference (F1,16=0.00). (c) Left- but not right-sided SNI decreased the 
percentage of time spent in the EPM open-arm indicating anxiety-like behavior (F2,37=3.888; 
P=0.03; SNI-R versus sham and SNI-L (P=0.05)). (d, e, f) The performance of SNI-R rats is 
impaired in PFC-dependent tasks. In the WM paradigm (d), the side of the SNI had an impact 
on animals’ performance (F2,48=4.987; P=0.01; SNI-R versus sham (P=0.01) and SNI-L 
(P=0.04)). Similarly, in the reversal steps 1-4 of ASST (e), the side of SNI had a significant 
effect (F(2,45)=14.522, p<0.001; F(2,45)=11.347, P<0.001; F(2,45)=46.343, p<0.001 and 
F(2,45)=24.661, P<0.001; respectively). SNI-R animals required a significantly higher number of 
trials to criteria than sham and SNI-L animals (P<0,001 in all comparisons). (f) The ability to 
refrain from responding when the delay-to-response was increased to 10 seconds (F(2,21)=7,884, 
P=0,003) was impaired in the SNI-R group when compared to both sham (P=0,01) and SNI-E 
(P=0,007). Results presented as mean±SEM. *P<0.05, **P<0.001, ***P<0.0001 (Tukey’s 
test). 
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Supplementary Methods 
 
Animals and surgery  
 
2 months old, male, Wistar han rats were used in all experiments. Animals were kept 
in a room with controlled temperature (22 ± 1ºC), 12 h light/dark cycle (lights on at 8 a.m.) 
and housed in groups of 2-3 animals in plastic cages with food and water available ad libitum. 
All procedures with animals were approved by the respective local organisms: Direcção Geral 
de Veterinária (Lisboa, Portugal) and The Experimental Animal Ethics Committee of the 
Provincial Government of Southern Finland (Hämeenlinna, Finland); and the experiments were 
performed according to the guidelines of European Communities Council Directive 
2010/63/EU. 
An experimental model of peripheral neuropathy was induced by a spared nerve 
injury (SNI)1. The unilateral axotomy and ligation of the tibial and common peroneal nerves on 
the left (SNI-L) or right (SNI-R) hindpaws was performed under 1,5:1,0 of ketamine 
(Imalgene)/medetomidine (Dormitor) at a dose of 1 mL/kg as described in detail elsewhere1. 
Briefly, the skin of the lateral surface of the thigh was incised and a section made directly 
through the biceps femoris muscle exposing the sciatic nerve and its three terminal branches. 
Following ligation and removal of 2–4 mm of the distal nerve stumps of the tibial and common 
peroneal nerves (the sural nerve was left intact), muscle and skin were closed in two layers. 
Sham-operated animals underwent identical surgical procedures (half of the group in the left 
and the remaining in the right paw) except that tibial and common peroneal nerves were left 
intact. After the surgery, animals were allowed to recover before the actual testing that was 
performed one month after the operation.  
Animals participating in the conditioned place preference (CPP) experiment had an 
intrathecal (i.t.) catheter for drug delivery to the spinal cord. The catheter (Intramedic PE-10, 
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Becton Dickinson and Company, Sparks, MD, USA) was placed at the level of the lumbarspinal 
cord under pentobarbital anesthesia (50 mg/kg i.p.) one week before actual testing, as 
described in detail elsewhere2. Following recovery from anesthesia, the correct placing of the 
catheter was verified by injecting lidocaine (4%, 7–10 µl followed by a 10 µl of saline for 
flushing) with a 50 µl Hamilton syringe (Hamilton Company, Bonaduz, Switzerland). Only those 
rats that had no motor impairment before lidocaine injection but had a bilateral paralysis of 
hind limbs following i.t. administration of lidocaine were studied further.  
 
Behavioral experiments  
 
All behavioral experiments were performed during the light period of the daily cycle. 
Acclimatization to the testing room was allowed for approximately 1h. To avoid possible bias, in 
particular related with the testing period, animals belonging to different groups were tested 
alternately (e.g. sham, SNI-L, SNI-R,…). 
 
Von Frey monofilaments. Development of neuropathic hypersensitivity was verified behaviorally 
in all animals. In the group undergoing CPP, this was done in the beginning before the 
installation of the i.t. catheter and was used to compare the lesion lateralization effect. In the 
remaining animals, hypersensitivity was assessed 1 week after the end of behavioral 
assessment to verify the successful development and maintenance of the neuropathy. Animals 
were habituated to the experimental conditions 1–2 h daily for 2 to 3 days. For assessment of 
tactile allodynia, the hind limb withdrawal threshold was determined by stimulating the sural 
nerve areas in the hind paw of the nerve-injured or sham-operated limb with monofilaments. 
The calibrated series of monofilaments used in this study produced forces ranging from 0.008 
to 60 g (North Coast Medical, Inc. Morgan Hill, CA, USA). The monofilaments were applied to 
the lateral foot pad with increasing force until the rat withdrew its hind limb. The lowest force 
producing a withdrawal response was considered the threshold. The threshold for each hind 
paw of each rat was based on three separate measurements and the median of these values 
was considered to represent the threshold. Limb withdrawal threshold was assessed in a 
separate session one month after nerve injury or sham operation.  
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Conditioned place preference (CPP). For analysis of ongoing pain one month after the nerve 
injury or sham operation, rats received spinal clonidine as previously described for a single 
conditioning trial protocol3. All rats underwent a 3 day habituation, in which they were placed in 
automated CPP boxes (Place Preference System, San Diego Instruments, Inc., San Diego, CA, 
USA) with access to all 3 chambers for 30 min per day. Time spent in each of the boxes was 
recorded for 15 min on day 3 (Supplementary Figure S1a). Rats that spent more than 720 s in 
one of the conditioning chambers were eliminated from the study. The following day (day 4), all 
rats received a morning injection of saline and were immediately placed in the appropriate 
pairing chamber for 30 min. Four hours later, all rats received clonidine and were immediately 
placed in the opposite chamber for 30 min. Testing, in which the animals were placed drug-
free in the CPP boxes with access to all chambers, occurred the following day (20 h following 
drug pairing). Clonidine hydrochloride (Sigma-Aldrich, St.Louis, MO, USA) was administered 
intrathecally at the dose of 10 µg and at the volume of 10 µl. Clonidine as well as saline 
control were flushed with 10 µl of saline. Clonidine and saline control injections were 
monitored by movement of an air bubble between the drug/saline control and the saline used 
for flushing. 
 
Elevated-plus maze (EPM). The EPM was performed in a plus-shaped maze made on black 
polypropylene plastic, with two opposed open arms (50.8 cm x 10.2 cm) and two opposed 
closed arms with the same dimensions but surrounded by walls (40.6 cm height; Med 
Associates Inc., St. Albans, Vermont, USA). The whole structure was elevated 72.4 cm from 
the floor and was surrounded by 4 black walls perpendicular and at equal distances from each 
arm of the maze. Animals were placed at the centre of the maze and allowed to explore for 5 
min. In the end of each trial all areas were cleaned with 10% alcohol and carefully dried. The 
number of arm entries and the time spent in each arm was registered. The percentage of the 
time spent in the open-arms is inversely related with anxiety-like behavior. The number of 
closed-arm entries was used as an index of locomotor activity. 
 
Working memory (WM) and Morris water maze (MWM). The WM and MWM tests were 
performed in a circular tank (diameter 170 cm) with black walls located in the center of a room 
with white walls where black geometric figures have been placed as spatial references. A video 
camera positioned in the ceiling captured the image to a video tracking system (Viewpoint, 
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Champagne au Mont d’Or, France). A black, circular (diameter 12 cm) platform was placed 
within one of the quadrants virtually assigned in the computer. During the tests the water 
temperature was kept in the range 22-24ºC and the level was such that it slightly covered the 
platform (therefore, invisible to the rats). In the beginning of each trial the animal was placed in 
the respective quadrant (Supplementary table 2) facing the maze walls. The trial was 
interrupted if the platform was found or if 120 seconds had elapsed (thereafter the animal was 
guided to the target). The animal was then allowed to spend 30 seconds in the platform before 
starting a new trial. In the WM paradigm, the daily trial-to-trial progression of the swim distance 
was averaged for the different platform locations, whereas in the MWM day-to-day progression 
(learning) was averaged across the 4 daily trials, for the same platform location.   
 
Attentional-set shifting task4. The ASST was performed in a rectangular arena (40 x 70 cm) with 
20 cm height walls. In one end of the arena a fixed divider created two compartments (20 x 20 
cm) each containing a bowl (7 cm diameter/ 4 cm depth) filled with sawdust, whose top was 
at the floor level. Near the opposite end, a removable divider placed 25cm from the wall 
created a waiting area (25 x 40cm). 6 days before the experiment, food availability was 
restricted to the last hour of the day cycle. In the first 3 days animals also received in their 
cages, during the morning, 2 pieces of Cheerios (Nestle, Portugal) per animal. In the second 3 
days, these rewards were delivered in the two bowls of the test arena, buried progressively 
deeper, until the animals become used to dig the media. The actual test spanned for 2 days, 
the first consisting of two simple discrimination tasks (odor and textures) and the last of 4 
compound discrimination/reversal task pairs. Rats performed each task until a criterion of 6 
consecutive correct trials was reached. Trials started by removing the divider of the waiting 
area and allowing the animal to explore the arena and terminated when the it excavated one of 
the bowls, only one of which was baited with ½ Cheerio. The location of the correct (baited) 
bowl varied in each trial according to a pre-established order (see Supplemental Table 3). In 
the odor and texture simple discrimination tasks, each bowl was marked with a different odor 
(aromatic oil) or texture (placed at the entrance of the choice compartments), respectively, one 
of which signaled the presence of the buried reward. In the compound tasks of the 2nd testing 
day, odors and textures (attentional dimensions) were simultaneously presented and the 
animal had to disregard the irrelevant dimension and focus on the relevant one. During each 
trial, procedures were similar to the ones described above. A first task in which odor was the 
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relevant cue was followed by its reversal (same odors and textures, but with the previously 
unbaited odor as the signal for reward), and then to a second pair of odors and textures, with 
odor the relevant dimension, at its reversal. Animals were then presented with a new group of 
odor and texture pairs, of which one texture was the relevant dimension, followed by its 
reversal, and a new group of odors/textures (with texture the relevant dimension) again 
followed for its reversal. Detailed information on the sequences used is presented in the 
Supplementary Table 3. The number of trials necessary to reach the criteria is used to 
compare the performances at each step. 
 
Inhibitory control to variable delay. This task was performed in the classical 5-choice serial 
reaction time task apparatus5, consisting in an nearly squared arena with 20cm tall walls, one 
being curved and having 5 apertures at the animal head level with nose-poke detectors and a 
light. In the opposite wall, a single aperture with similar dimensions is connected to a food 
dispenser. In this test, only the middle aperture out of the 5 nose-poke apertures was available 
(the remaining 4 were closed). The day before the first session, food was removed from 
animals’ cages and thereon its availability was restricted to the last hour of the light cycle. 
Animals were trained to nose-poke the open aperture in order to receive a sugar pellet 
(dustless precision pellets; Bio-Serv, Frenchtown, US). Each trial in the training sessions 
started with the house-light on, signaling an ongoing trial. After a 3 seconds delay interval, the 
light-signaling aperture lighted up. A nose poke before the signal (impulsive response) 
interrupts the trial and initiates a “punishment” period of 5 seconds (house light off). On the 
other hand, a nose poke after the signal triggers a pellet deliver. Each training session spanned 
for 30 min or 100 trials. After nine training sessions all animals were able to accomplish 100 
trials and, except for two (1 sham and one SNI-L), had less than 30% of impulsive responses. 
The 10th session animals were tests in a sequence of 25 trials at 3 seconds delay, followed by 
70 trials at 7 or 10 seconds delay attributed randomly by the computer and returning finally to 
3 seconds delay for more 25 trials. In this session premature responses were not punished. 
The total number of premature responses per total amount of delay time, were used to 
compare groups’ performances.       
 
Statistics 
 
76
The data are presented as mean ± S.E.M. and analyzed using one- or two-way 
analysis of variance (1-w- or 2-w-ANOVA) or repeated measures of variance, accordingly, 
followed by Tukey’s post-hoc test for multiple comparisons (comparison of three or more 
groups), or t-test (comparison of two groups). P<0.05 was considered to represent a significant 
difference. 
  
 
Supplementary References 
 
1. Decosterd, I. & Woolf, C.J. Pain 87, 149-158 (2000). 
2. Storkson, R.V., Kjorsvik, A., Tjolsen, A. & Hole, K. J Neurosci Methods 65, 167-172 
(1996). 
3. King, T., et al. Nat Neurosci 12, 1364-1366 (2009). 
4. Birrell, J.M. & Brown, V.J. J Neurosci 20, 4320-4324 (2000). 
5. Bari, A., Dalley, J.W. & Robbins, T.W. Nat Protoc 3, 759-767 (2008). 
 
77
Supplementary figure 1 
During pre-conditioning period, the animals failed to show preference for any of the chambers 
(F1,26=0.45; p=0.51), independent of the experimental group (F2,26=0.24; p=0.79;). Drug and 
saline indicate whether the chamber was paired with clonidine or saline treatment in the 
following day. Data presented as mean + S.E.M. 
  
 
Supplementary figure 2 
EPM closed-arms (CA) entries. Neither left- or right-sided SNI influences the number of CA 
entries (F2,37=1.640; p=0.21) indicating that the groups do not differ regarding their locomotor 
activity. Data presented as mean + S.E.M. 
 
 
Supplementary figure 3 
The learning curves in the Morris water maze spatial reference memory task are given as the 
average daily gain in reference to day 1. A multivariate analysis indicates that SNI has no 
significant effect on the ability to learn the platform location F(2,48)=1.628 (p=0.21). Data are 
presented as mean + S.E.M.   
 
Supplementary figure 4 
All steps of the ASST are presented. Except for the reversal steps (see main text) no differences 
were found between groups particularly in the Extra-Dimensional Shift (F(2,45)=2.949, p=0.063) 
indicating that PFC medial areas are apparently spared after SNI. Data presented as mean + 
S.E.M.
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Supplementary table 1 
 Starting quadrant 
day platform location Protocol T1 T2 T3 T4 
1 W WM N S W E 
2 N WM W N S E 
3 E WM E S N W 
4 S WM/MWM E W N S 
5 S MWM N S E O 
6 S MWM S N O E 
7 S MWM O E S N 
 
Supplementary table 1. Sequence and organization of the WM and MWM tests. Platform 
location on each day and the starting quadrant on each trial are given. Note that when the 
animal initiates the trial in the quadrant where the platform is located (bold), there exists an 
increased chance of finding the platform by accident. To avoid this possible bias, these trials 
were distributed evenly in the four days.  
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Supplementary table 2 
 L R L R L R L R L R L R L R L R L R L R 
trial 1 2 3 4 5 6 7 8 9 10 
SDodo O2 O1 O1 O2 O1 O2 O2 O1 O1 O2 O2 O1 O2 O1 O2 O1 O1 O2 O1 O2 
SDtex T2 T1 T1 T2 T1 T2 T2 T1 T1 T2 T1 T2 T1 T2 T1 T2 T2 T1 T2 T1 
O3 O4 O4 O3 O4 O3 O4 O3 O3 O4 O3 O4 O4 O3 O4 O3 O3 O4 O3 O4 
CD 
T3 T4 T3 T4 T4 T3 T4 T3 T4 T3 T3 T4 T3 T4 T3 T4 T4 T3 T4 T3 
O3 O4 O3 O4 O3 O4 O4 O3 O4 O3 O3 O4 O4 O3 O4 O3 O3 O4 O4 O3 
Rev1 
T4 T3 T4 T3 T4 T3 T4 T3 T3 T4 T3 T4 T3 T4 T4 T3 T3 T4 T3 T4 
O5 O6 O5 O6 O5 O6 O6 O5 O6 O5 O6 O5 O6 O5 O6 O5 O5 O6 O5 O6 
IDS1 
T5 T6 T5 T6 T6 T5 T5 T6 T6 T5 T5 T6 T5 T6 T6 T5 T6 T5 T6 T5 
O6 O5 O5 O6 O5 O6 O5 O6 O6 O5 O6 O5 O5 O6 O6 O5 O6 O5 O5 O6 
Rev2 
T5 T6 T6 T5 T6 T5 T5 T6 T6 T5 T5 T6 T5 T6 T6 T5 T6 T5 T6 T5 
O7 O8 O8 O7 O7 O8 O7 O8 O7 O8 O8 O7 O7 O8 O8 O7 O8 O7 O8 O7 
EDS 
T7 T8 T8 T7 T7 T8 T7 T8 T8 T7 T8 T7 T8 T7 T8 T7 T7 T8 T7 T8 
O8 O7 O8 O7 O7 O8 O7 O8 O7 O8 O8 O7 O8 O7 O8 O7 O7 O8 O7 O8 
Rev3 
T7 T8 T7 T8 T7 T8 T8 T7 T7 T8 T8 T7 T8 T7 T8 T7 T7 T8 T8 T7 
O9 O10 O9 O10 O10 O9 O9 O10 O9 O10 O10 O9 O10 O9 O9 O10 O10 O9 O10 O9 
IDS2 
T9 T10 T10 T9 T9 T10 T9 T10 T10 T9 T10 T9 T10 T9 T10 T9 T9 T10 T9 T10 
O9 O10 O10 O9 O9 O10 O9 O1 O9 O10 O10 O9 O10 O9 O9 O10 O9 O10 O10 O9 
Rev4 
T9 T10 T9 T10 T9 T10 T10 T9 T9 T10 T9 T10 T10 T9 T10 T9 T9 T10 T10 T9 
 
Supplementary table 2. Odor and texture presentation at each ASST trial. If at the 10th trial the 
learning criteria was not successfully achieved the sequence was restarted. Odors: O1-
strawberry; O2-camellia; O3-lemon; O4-papaya; O5-rose; O6-vanilla; O7-lotus; O8-cinnamon; O9-
mango; O10-eucalyptus; Textures: T1-styrofoam; T2-sponge; T3-sandpaper; T4-scourer; T5-sponge 
cloth 1; T6- sponge cloth 2; T7-cardboard; T8- velvet; T9-carpet; T10-foam. L-left compartment; R-
right compartment. 
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3. Results and discussion 
 
 
The work presented in this thesis illustrates the detrimental effect of chronic neuropathic pain 
on emotional and cognitive behaviour. It is in its conception a descriptive analysis, supported 
by a wide battery of behavioural tests. The spared nerve injury (SNI) model of chronic 
peripheral neuropathic pain was used in all experiments standardized to a 1 month period of 
undisturbed development. By keeping constant these two factors, i.e. model and neuropathy 
duration, the influence of two other variables, (i) the age of the animal at the time of pain onset 
and (ii) the laterality of the nerve lesion, were studied. The working hypotheses raised in each 
of these two cases shared a common ground, the neuropathy as a degenerative process that 
affects not only the primordial neuropathic spot but also remote areas of the nervous system 
either by degeneration (e.g. Wallerian), aberrant synaptic transmission, inflammation or a 
combination with variable degrees of contribution. In peripheral neuropathies, as is the case of 
the model adopted in the studies integrating this thesis, the areas being immediately affected 
are the spinal cord (or brainstem nuclei if a cranial nerve is affected) and the dorsal column 
nuclei, or to put it differently, areas where the affected nerves establish their first synapse. 
There, a cascade of events follows at molecular, cellular and morphological levels with 
immediate manifestations of abnormal sensation and hypersensitivity. Human and animal 
studies in the past years revealed that cortical and subcortical areas are also subject to plastic 
transformation as a consequence of prolonged pain and that these are temporally coincident 
with the emergence of altered emotional and cognitive behaviours. However, animal models 
have shown inconsistent results concerning the manifestation of these traits, suggesting that 
these models are not thoroughly characterized. The effects of age at pain onset and of 
lateralization of pain on such manifestations are discussed as well as the potential involvement 
of the prefrontal cortex (PFC).   
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3.1. Experimental considerations 
 
 
3.1.1. Animal model and pain assessment  
 
Over the last decades, a significant number of chronic pain animal models have been 
developed modelling different aspects of clinical chronic pain syndromes (reviewed in section 
1.3.1.; Bennett et al., 2003; Martin et al., 2003; Jarvis and Boyce-Rustay, 2009; Bennett, 
2010; Colleoni and Sacerdote, 2010; Jaggi et al., 2011). The SNI model (Decosterd and 
Woolf, 2000) was adopted in the experimental work presented in this thesis. Briefly, it consists 
in the ligation and distal axotomy of the tibial and common peroneal branches of the sciatic 
nerve, preserving a third branch, the sural nerve. Characteristic signs of neuropathy emerge a 
few hours after the surgery, including mechanical/temperature allodynia and hyperalgesia. 
Importantly, the model is temporally stable in time making it particularly suited for long 
experiments. This, allied with its technical simplicity and reproducibility, were the main reasons 
for its selection. 
 
In all experiments, the model was installed 1 month prior to the initiation of the behavioural 
studies in male Wistar Han rats. During this period animals were handled in a random 
schedule to prevent habituation while reducing bias due to novelty exposure stress. Aging 
studies included three groups of animals aged 2, 9 and 21 months. The SNI lesion was 
installed on the left side in this case. In the lateralization studies, 2 months-old animals were 
used. The SNI was installed either in the left or right side. Von Frey calibrated filaments were 
used in all cases to access the occurrence of mechanical allodynia (Chaplan et al., 1994), a 
hallmark of ongoing neuropathy. This assessment was performed at the end of the behavioural 
tests to prevent any interference. Additionally, analgesia conditioned place preference (CPP) 
was also employed in the lateralization experiments to assess ongoing pain (King et al., 2009).  
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3.1.2. Behavioural paradigms 
 
3.1.2.1. Emotional behaviour 
 
Elevated plus maze 
 
The elevated-plus maze (EPM) test is the gold-standard paradigm used for testing anxiety-like 
behaviour in rodents (Handley and Mithani, 1984; Pellow et al., 1985; Sousa et al., 2006). It 
consists in an elevated plus shaped maze with opposing open and closed arms. The rationale 
of the test lays on the conflict between the innate drive to explore novel spaces and the 
aversion to open areas that occurs in rodents. Anxious behavioural profiles are correlated with 
shorter periods of time spent in the open arms. The validity of the test has been extensively 
documented (Cruz et al., 1994; Rodgers and Johnson, 1995; Rodgers and Dalvi, 1997; Wall 
and Messier, 2001). 
 
Forced swimming test  
 
The forced swimming test (FST) was conceived in the mid 1970’s as a screening test for 
putative antidepressant properties of drugs in rodents (Porsolt et al., 1977a; Porsolt et al., 
1977b; Porsolt et al., 1978). In this paradigm the animal faces an inescapable aversive 
scenario (a cylinder filled with water) leading to a condition of learned helplessness that is a 
hallmark of depressed individuals. The perseverance of the animal to escape the situation 
inversely correlates with depressive-like behaviour. The FST has been extensively validated and 
is the most common test used to assess depressive-like behaviour in rodents (Cryan et al., 
2005; Petit-Demouliere et al., 2005; Sousa et al., 2006).  
 
3.1.2.2. Cognitive behaviour 
 
A battery of cognitive tasks was selected to study the effect of chronic pain on cognitive 
performance (Sousa et al., 2006). Successful performance in the majority of these tasks is 
known to be dependent on the PFC functional integrity (for detailed discussion see 3.4.; Dalley 
et al., 2004; Robbins and Arnsten, 2009). This option was made based on the consistent 
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findings of morphofunctional maladaptative plasticity in this area during chronic pain 
conditions (see 1.3.2.). Morris water maze (MWM), a hippocampal dependent task, was used 
for comparison (Morris, 1984). 
 
Working memory 
 
A number of tasks have been envisaged to test for working memory (WM) in rodents 
(Dudchenko, 2004). In the set of studies performed, the spatial WM version of the MWM (see 
below for details) was used (Frick et al., 1995). The task was performed in a circular pool of 
water where a platform was accessible but concealed slightly below the water level. Each day, 
for four consecutive days, the platform location was changed and the animal was given four 
trials to learn it. Therefore, information concerning the platform location had to be acquired 
(first trial) and retrieved (remaining trials). The trial-to-trial progression was analysed in terms of 
the amount of time (or swam distance) elapsed to reach the platform. We also analysed MWM 
long-term spatial reference memory for comparison. In this case the platform location was kept 
in the same location for four consecutive days. The daily progression in terms of the amount of 
time (or swam distance) elapsed to reach the platform was analysed. Water mazes are 
advantageous over other WM and long term memory paradigms in many aspects (Dudchenko, 
2004); food or water deprivation are not required as the motivating stimulus, i.e. escaping 
from the water, an innate behaviour in rodents and, additionally, intramaze cues (e.g. odours) 
are nearly absent. The principal disadvantage relates to the fact that the animal can adopt 
other strategies, namely egocentric orientation, not related with the rational of WM or MWM.  
 
Reversal learning 
 
Reversal following MWM acquisition. The classical MWM was applied as originally described 
(Morris, 1984). After the fourth day of MWM, the platform location was finally moved to a new 
location. The percentage of time (or distance) spent in old and new quadrants were used as an 
index of reversal learning ability.  
 
Attentional-set shifting task (ASST). The ASST is an analogue of the Wisconsin Card Sorting test 
(Berg, 1948; Milner, 1963; Monchi et al., 2001) that has been adapted for primates (Dias et 
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al., 1996a, b, 1997) and rodents (Birrell and Brown, 2000). The test consists in the sequential 
acquisition and reversal of rules regarding information leading to a reward (Birrell and Brown, 
2000). The rule indicating a food reward is constantly being shifted either within or between a 
perceptual dimension (odour or texture). The set of cues consists of two different odours and 
two different textures, being simultaneously presented to the animal (compound discrimination, 
CD). In the first CD, the reward was associated with one of the odours. Following a successful 
acquisition (six consecutive rewarded trials), the reward was then associated with the second 
odour - reversal (R1). Once the criterion was attained, new pairs of odours and textures were 
introduced. The procedure was repeated in a first instance maintaining the perceptual 
dimension - intradimensional shift (IDS1)/R2 – and then changing it to textures - 
extradimensional shift (EDS)/R3. Finally, an IDS2/R4 was performed. The ASST is 
advantageous over the MWM/reversal as it allows to discriminate PFC subfunctions (see 
below; Birrell and Brown, 2000) and limits the use of alternative strategies, e.g. egocentric 
orientation. Food deprivation is required, but only for a short period of time and thus it should 
not constitute a major drawback.  
 
Impulsivity 
 
The 5-choice serial reaction time task (5-csrtt) was primarily selected to test impulsive 
behaviour (Carli et al., 1983; Robbins, 2002; Bari et al., 2008). The rational behind the task 
follows that of Leonard’s 5-csrtt developed to study sustained attention in humans (Leonard, 
1959). In this task animals are trained to poke the nose in a lighted aperture out of five 
possible choices in order to gain a sugared reward. The attentional demand of the task is 
increased by successively decreasing the light signal duration whenever the animal reaches 
accuracy levels over 80%. We found that the amount of sessions needed to reach the last level 
varied substantially between animals (from 3 weeks up to 2 months), independently of their 
experimental condition. However, in this level we had a strong indication that right-sided SNI 
animals presented increased levels of impulsive responses. To validate this observation, we 
designed a delay-to-signal task, focusing on the impulsive response. In this task, the light signal 
was presented with variable delays but in a fixed location. The total number of premature 
responses (i.e. nose pokes during the delay period) was compared between the groups. This 
task is advantageous over the 5-csrtt in that animals learn it faster (up to 8 days) and more 
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homogeneously, implying a shorter period of alimentary restriction. Additionally, the attentional 
component is minimized facilitating the interpretation of the results. 
 
 
3.2. Impact of neuropathic pain on emotional behaviour 
 
The association between chronic pain and mood disorders is extensively documented in 
human subjects (Blackburn-Munro and Blackburn-Munro, 2001; Wiech and Tracey, 2009). It is 
bidirectional in the sense that both chronic pain potentiates the emergence of mood disorders 
(Dworkin and Gitlin, 1991), but also in that the latter can increase the risk for chronic pain 
(Magni et al., 1994; Carroll et al., 2004; Larson et al., 2004). Additionally, in the past decade 
it was demonstrated that animal models of prolonged pain also manifest altered emotional 
behaviour, particularly anxiety- and depressive-like behaviour, paving the way for a new 
comprehension of the pathophysiology of deteriorated emotional behaviour in the context of 
chronic pain. However, results obtained by different researchers greatly diverge. This derives to 
a great extent from the experimental heterogeneity among the different studies (see table I) as 
factors as specie, strain, gender, age, husbandry and testing procedures are known to greatly 
influence the outcome measures (Mogil, 2009). These will be briefly discussed below.  
 
Strain/genetic background. There is currently no experimental evidence that the genetic 
background influences the expression of emotional disorders in animal models of prolonged 
pain. However, this is highly probable as, when analysed individually, pain-related behaviours 
(LaCroix-Fralish et al., 2005) and anxiety/depression manifestations (O'Neil and Moore, 2003; 
Hamet and Tremblay, 2005; Malkesman and Weller, 2009) greatly depend on the genetic 
background. Furthermore, two reports have consistently demonstrated that increased levels of 
basal trait anxiety are predictive of increased pain-like behaviours in neuropathy models (Vatine 
et al., 2000; Roeska et al., 2009).  
 
Gender. All information concerning the impact of chronic pain on emotional behaviour has 
been obtained in male subjects (table I). Therefore gender cannot account for the diversity of 
published results. However it is expectable that gender plays a role, not only because 
emotional traits present gender-related differences in basal conditions (Palanza, 2001) but also 
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because sexual hormones modulate pain perception (Craft et al., 2004; Aloisi and Bonifazi, 
2006).  
 
Pain duration. In chronic pain models, manifestations of abnormal emotional behaviour are 
delayed in relation to the emergence of pain behavioural signs. Most probably, this reflects 
different kinetics on the plastic adaptations taking place in the supraspinal centers and dorsal 
horn, respectively (see 1.3.2.). Additionally, distinct traits of emotional behaviour, like anxiety 
and depression, present a temporal mismatch in their manifestations, the former preceding 
the latter (Suzuki et al., 2007; Yalcin et al., 2011). Thus, the duration of the neuropathy in 
experimental studies is probably one of the factors mostly associated with the variability on the 
reported results (table I).  
 
Pain model. A small number of studies (see table I) demonstrated that the emergence of 
emotional disturbances depend on the type of pain model used. Comparative analyses indicate 
that models associated with lower withdraw thresholds to mechanical stimulation are more 
anxiogenic, suggesting that pain magnitude can be a determinant factor triggering abnormal 
affective behaviour (Hasnie et al., 2007a; Roeska et al., 2008).  
 
Experimental conditions. Factors related with the experimental organization and husbandry 
impact on the manifestation of behavioural traits (Sousa et al., 2006; Rice et al., 2008; Mogil, 
2009). Although these are not always described with detail in the scientific reports, some 
possible sources of bias can be detected including nociceptive testing immediately prior to 
anxiety assessment or test repetition in paradigms that require novelty, for instance. 
 
The impact on emotional behaviour on parameters such as age at the time of pain onset and 
anatomical location of the pain focus, namely its lateralization, were unexplored when the 
experimental work of this thesis was initiated. Both parameters were considered fundamental 
to the overall characterization of the phenomena in the animal model and, most of all, to guide 
further research on the underlying pathophysiology.  
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Table I. Evaluation of anxiety- and depression-like behaviour in chronic pain models 
trait paradigm species/strain model age side overall effect references 
anxiety EPM; DB/LB rat; SD SNL y l No differences were detected between injured and sham controls at day 14; Kontinen et al., 1999 
 EPM; DB/LB mouse; B6 PSNL; CFA y r Anxiety-like behaviour in the EPM and DB/LB at day 28; EPM tested at 7(b) and 28(a,b) day; 
DB/WB tested at 7(a,b), 14(a), 21(a) and 28(a,b) day; 
Narita et al., 2006a; Narita et 
al., 2006b 
 OF rat; Wistar VZV; PSNL; SNT y l Positive correlation between mechanical hypersensitivity and anxiety in the VZV and SNT 
models at day 14; 
Hasnie et al., 2007a 
 EPM; OF mouse; B6 PSNL y l No differences were found at days 7, 14 and 28;  Hasnie et al., 2007b 
 OF; DB/LB; EPM mouse; B6 SNL y l Signs of anxiety-like behaviour at post-surgery week 8 in all paradigms1; Suzuki et al., 2007 
 OF rat; Wistar PSNL; gp120 y l Signs of anxiety-like behaviour at day14; a second group was tested at day 7 but has not 
manifested any alteration; 
Wallace et al., 2007 
 OF rat; Wistar ddC; ddC+gp120 y syst; syst/l Signs of anxiety-like behaviour at day 14 (ddC+gp120) and 21 (ddC); Wallace et al., 2007b, 2008 
 EPM mouse; B6 SC y r Anxiety-like behaviour at day 30; Benbouzid et al., 2008 
 DB/LB; EPM mouse; B6 PSNL y r Anxiety-like behaviour at post-surgery day 27 in both paradigms; Matsuzawa-Yanagida et al., 2007 
 OF; EPM rat; Wistar SNI y r No signs of anxiety-like behaviour at day 60; Goncalves et al., 2008 
 EPM rat; Wistar CCI; PSNL y l Anxiety-like behaviour at day 28 (CCI); ≈ 40% less time in the OA PSNL compared to sham 
(no statistical significance); 
Roeska et al., 2008 
 EPM rat; Wistar (HAB and LAB) CCI y n/a2 Anxiety-like behaviour both in HAB and LAB animals at post-surgery day 36; Roeska et al., 2009 
 OF mouse; ddY PSNL y r No signs of anxiety-like behaviour at at post-surgery days 7-9; Kodama et al., 2011 
 OF; EZM; mb mouse; Balb/c and B6 SNI; CCI; CFA y l Results vary according to the paradigm, sp/st and model 30 days after pain onset. 
Generally, no alterations or decreased anxiety; 
Urban et al., 2011 
 DB/LB; mb; NSF mouse; B6 SC n/a r Increased anxiety from the 4th up to the 8th post-surgery week;  Yalcin et al., 2011 
depression FST rat; SD SNL y l No differences were detected between injured and sham controls; Kontinen et al., 1999 
 TST mouse; B6 PSNL y l No differences were found at post-surgery days 7, 14 and 28; Hasnie et al., 2007b 
 FST mouse; B6 SNL y l Depressive-like behaviour at post-surgery week 8; Suzuki et al., 2007 
 TST mouse; B6 SC y r No differences were detected between injured and sham controls; Benbouzid et al., 2008 
 FST rat; Wistar SNI y r Depressive-like behaviour at day 60; Goncalves et al., 2008 
 FST rat; Wistar CCI y l Depressive-like behaviour at post-surgery day 21-28; Hu et al., 2009 
 FST mouse; B6 SNI y r Depressive-like behaviour at post-surgery day 7; Norman et al., 2009 
 FST rat; SD SNL (L5) y n/a Depressive-like behaviour at post-surgery day 29; Hu et al., 2010 
 FST; SPT mouse; Balb/c and B6 SNI; CFA y l No alterations up to post-surgery day 40; Urban et al., 2011 
 Splash test; FST mouse; B6 SC n/a r Depressive-like behaviour at post-surgery weeks 6-9; Yalcin et al., 2011 
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 Table I. Summary of the literature concerning the effects of chronic pain in anxiety- and depression-like behaviour in rodent models. Male animals were used in all 
studies. Abbreviations: CCI – chronic constriction injury; CFA - complete Freund’s adjuvant; DB/LB – dark/light box; ddC – 2'-3'-dideoxycytidine (zalcitabine; 
antiretroviral agent); EPM – elevated-plus maze; EZM – elevated-zero maze; FST – forced swimming test; gp120 - immunodeficiency virus type I envelope 
glycoprotein 120; HAB – high anxiety-like behaviour; l – left; LAB – low anxiety-like; mb – marble burying; n/a – not applicable (available); OF – open-field; NSF – 
novelty suppressed feeding test; PSNL – partial sciatic nerve ligation; SC sciatic nerve cuffing ; SD – Sprague-Dawley; SNI – spared nerve injury; SNL – spinal nerve 
ligation; SPT – sucrose preference test; syst – systemic; r – right; SNT - spinal nerve transection; TST - tail suspension test; VZV - Varicella zoster virus ; y – young. 
Notes: 1 in a second experiment, a group of animals was tested at post-surgery days 2, 7, 15 and 30; depressive- and anxiety-like behaviours manifested at days 15 
(FST) and 30 (OF, EPM), respectively; 2left-sided in previous reports. 
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3.2.1. Age effect 
 
In chapter 2.1. of this thesis we demonstrated that young and old SNI animals had an 
increased anxiety-like behaviour when compared to the respective age-matched sham controls. 
On the contrary, mid-aged SNI and sham-operated animals presented a similar behavioural 
profile in the EPM. A substantial decrease in the percentage of time spent in the open-arms by 
the sham group (and not a recovery of SNI) accounts for this result in mid-aged animals. 
Additionally, there was an age-related increase in the anxiogenic profile which is in accordance 
with the observations made by others (Lamberty and Gower, 1990; Frussa-Filho et al., 1992; 
Lamberty and Gower, 1992; Li et al., 1995; Boguszewski and Zagrodzka, 2002; Bessa et al., 
2005; Pego et al., 2006; Meyza et al., 2011; Moretti et al., 2011). Importantly, the presence 
of the neuropathic lesion seemed to contribute to accelerate the aging trend.  
 
On the contrary, young and old SNI animals do not display major differences in the 
manifestation of depressive-like behaviour in the FST, as assessed both by the latency to 
immobility and the immobility parameters, when compared with the respective age-matched 
controls. Curiously, mid-aged controls and SNI differed significantly as a result of a decreased 
immobility in the sham group (when compared with young and old sham groups). This age-
related pattern observed in the sham group was in accordance with studies performed by 
others (Miyagawa et al., 1998; Zambrana et al., 2007). Taking into account the data obtained 
in the EPM it is apparently paradoxical that in the FST, SNI did not trigger a deterioration of the 
emotional response. However, a recent study suggests that depressive-like behaviour in 
rodents with neuropathic pain is a late onset phenomena emerging around the 8th week after 
the neuropathy installation (Yalcin et al., 2011), which may justify the absence of depressive-
like manifestations in our animals (4-week neuropathy). This observation is not consensual but 
other studies seem to support this possibility (see table I; Suzuki et al., 2007; Goncalves et al., 
2008). 
 
The pathophysiology underlying altered emotional behaviour in chronic pain conditions remains 
largely unknown. Comparable behavioural impairments are observed in chronic stress 
conditions largely as a result of a sustained activation of the hypothalamic-pituitary-adrenal axis 
(HPA). Neuropathic pain is an inescapable stressor and in this context some groups measured 
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the levels of circulating adrenocorticotropic hormone (ACTH) and corticosterone (Bomholt et 
al., 2005; Ulrich-Lai et al., 2006; Norman et al., 2009; Yalcin et al., 2011) as well as thymus 
and adrenal weights (Ulrich-Lai et al., 2006) to conclude that they were unaltered. However, 
the expression of corticotropin releasing factor (CRF) and glucocorticoid receptor (GR) were 
found to be increased in the Amy (and the latter also in the hippocampus) but not in the 
hypothalamic paraventricular nucleus (PVN), which is a central area in the HPA axis. 
Furthermore, CRF receptor antagonism was demonstrated to diminish pain-related (acute 
inflammatory condition) anxiety (Ji et al., 2007). Additionally, in a chronic SNI condition, 
blockage of CRF binding protein (implying increased free CRF) was shown to increase the 
preference for the dark compartment of the dark/light box (DB/LB) paradigm (LaBuda and 
Fuchs, 2000) reflecting an anxiogenic effect (Bourbia et al., 2010). The interpretation of this 
effect has however to account for the dual pro- and anti-nociceptive actions of CRF (Ji and 
Neugebauer, 2008; Bourbia et al., 2010). Altogether, the available data support the idea that 
the underpinnings of emotional disturbances associated with chronic pain are mainly extra-
HPA. During the ageing process, on the other hand, it is known that the regulatory 
mechanisms of the HPA axis are altered toward an increased level of circulatory ACTH and 
corticosteroids and that the inhibitory feed-back loop is less effective when a HPA response is 
mounted (Sapolsky, 1999; Pedersen et al., 2001). It is therefore probable that both systems 
concur to the overall modulation of emotional behaviour, explaining the potentiation of the SNI 
effect observed in the aged animals. 
 
Alternatively, the hypothesis of a neuro-immune contribution to the modulation of emotional 
behaviour has been gaining currency. In this context, the observation of an increased 
expression of interleukin 1β (IL-1β) in the brainstem, thalamus and PFC in neuropathic pain 
models (Apkarian et al., 2006; Norman et al., 2009) and, particularly, an IL-1β receptor 
antagonism mediated rescue of a depressive-like behaviour in the same conditions seems to 
support such view (Norman et al., 2009). It should be noticed that the magnitude of IL-1β 
expression differed between the two models of neuropathic pain used by Apkarian and 
colleagues (2006), evidencing the singularity of each model. Additionally, alterations of 
opioidergic function in the Amy (Narita et al., 2006a) and PFC (Narita et al., 2006b) have been 
associated with abnormal emotional behaviour in chronic pain conditions, further highlighting 
the multifactorial character of the phenomenon.  
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3.2.2. Lateralization effect 
 
Animals with left-sided SNI manifested increased anxiety-like behaviour when compared with 
both right-sided SNI and the sham control (chapter 2.2). Measurements of either evoked or 
ongoing pain showed no differences that could account for our observations. Only two human 
studies by Gagliese and colleagues tested putative differential effects of lateralized pain on 
emotional behaviour and both concluded similarly, i.e., left-sided pain is more anxiogenic 
(Schiff and Gagliese, 1994; Gagliese et al., 1995). On the other hand, innumerable animal 
studies greatly diverge on results (see table I). These discrepancies may relate to the diversity 
of pain models, time points for behavioural assessment, the usage of strains that differ on 
basal conditions in emotional manifestations and incorrect organization of the behavioural tests 
(some authors report pain tests prior to EPM) hindering any comparison. This point will be 
further discussed in section 3.4. in the context of spinal cord ascending pathways to the PFC, 
a potential mediator of the lateralized effect. 
 
 
3.3. Impact of neuropathic pain on cognitive performance 
 
It has been recognised that individuals with chronic pain frequently display impaired attention 
and a slower ability to process information (Moriarty et al., 2011). Some authors attributed 
such impairments to the presence of a highly salient and perseverant stimulus – pain – that, 
by consuming processing capacity, diminishes the efficient process of other types of 
information (Eccleston, 1994, 1995; Legrain et al., 2009). Brain imaging studies, namely the 
seminal studies by Apkarian and colleagues would, however, reveal a different picture 
(Apkarian et al., 2004). In this report, it was concluded that individuals with chronic pain 
presented severe structural alterations in cortical areas involved in cognitive function, namely 
the prefrontal cortex (PFC). To put it in the authors’ own words “…the brain of a chronic pain 
patient is not simply a healthy brain processing pain information, but rather is altered by the 
persistent pain in a manner reminiscent of other neurological conditions associated with 
cognitive impairments.” (Baliki et al., 2008). Until very recently, the effect of chronic pain in 
cognitive performance was largely uncharacterized in the animal model. Importantly, none of 
the studies available was concerned with the distinction between affected and spared cognitive 
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domains, a fundamental aspect of validity of the model as a correlate of human pathology. This 
scenario prompted us to initiate a series of behavioural tests aiming to further clarify this issue. 
The organization rationale of the cognitive tests was similar to that followed in emotional 
behavioural studies (section 3.2.) both in terms of the pain model selected as well as of the 
parameters age and laterality of pain focus. Finally, the experimental considerations raised on 
section 3.2. concerning the impact of factors as strain, gender, pain model, among others, on 
the emotional behaviour, also apply in the context of cognitive studies. However, the scarcity of 
published reports hinders any detailed comparative analyses on each of these factors (table II).  
 
3.3.1. Age effect 
 
In chapter 2.1. we demonstrated that the increased age of the experimental subject was a 
determinant factor for poorer performances in the reversal learning task, marginally significant 
for WM task and not relevant for the performance in the MWM. Chronic pain (left-sided SNI) 
was detrimental for the performance only in the reversal task affecting specifically the mid-aged 
group, mid-aged sham operated animals performance being comparable to that of young (SNI 
and Sham) animals and that of mid-aged SNI comparable to old (SNI and sham) animals. 
 
Aging seemed to be selectively detrimental in the tasks that are more dependent on the 
functional integrity of the PFC, i.e., reversal learning, and spared the hippocampal dependent 
MWM. WM task depends on the hippocampal-to-PFC communication (Cerqueira et al., 2007) 
and in that sense it is not surprising that the performance on this task was also affected by 
aging though not as severely as the reversal learning task. In agreement with our observations, 
in a cross sectional study in humans, negative associations between volume and age were 
found to be stronger in the PFC than in the hippocampus in (Raz and Rodrigue, 2006). It 
should however be acknowledged that interindividual heterogeneity concerning the onset and 
the affected brain areas has been found in a longitudinal study on healthy subjects (Raz et al., 
2005). 
 
Current data on the association between pain and age is controversial, some authors 
defending a putatively increased algesic quality of neuropathies in mid-aged individuals while 
others not (Gagliese and Melzack, 2000). In our experiments we showed that pain-related 
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behaviours evoked by stimulation of the affected dermatomes with calibrated Von frey 
filaments did not differ between young, mid-aged and old animals and, therefore, pain intensity 
should not be an accountable factor for the cognitive impairment observed.  
 	  
3.3.2. Lateralization effect 
 
Following the initial studies on aged animals (chapter 2.1.), the PFC emerged as a probable 
candidate mediating the observed behavioural effects considering that its dependent functions 
appeared particularly vulnerable in chronic pain conditions. We have therefore increased the 
battery of cognitive tests in the second series of experimental work in order to test for other 
PFC-dependent functions like impulse control and attentional-set shifting (see chapter 2.2.). We 
demonstrated that in all these paradigms animals with right-sided neuropathy had consistently 
poorer performances when compared to sham operated animals or left-sided SNI animals. 
Importantly, we have found no differences in the hippocampal dependent MWM reinforcing the 
idea that the SNI lesion, particularly when right-sided, is more detrimental for PFC-dependent 
functions. 
 
In the spatial reference WM test we observed that the trial-to-trial average distance difference in 
the water maze was significantly smaller in rats with a right-sided neuropathy when compared 
to left-sided and controls, reflecting an impaired learning ability. Contrary to our observations, 
in a recently published study (table II; Ren et al., 2011) left-sided SNI animals were found to 
have an impaired WM performance in the 8-arm radial maze (8-arm; Olton and Samuelson, 
1976). The paradigms used in the two studies, although sharing a common rationale, differ 
significantly in many aspects (Sharma et al., 2010), which can possibly account for the 
observed differences. A curious aspect of the 8-arm study is that while control animals 
demonstrate a clear learning curve, stabilizing on the 3rd day close to their best performance, 
SNI maintain a stable performance throughout the entire experimental period (9 days), i.e., 
these animal do not learn. This fact strongly suggests that stereotypic strategies (e.g. clockwise 
movements), not related with WM, might be operating (Dubreuil et al., 2003). 
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In the ASST we observed that right-sided SNI animals required more trials to accomplish the 
criteria in the reversal (R1-4) steps. Curiously, in the EDS step no differences were detected 
between groups. EDS and reversal have been demonstrated to depend on the functional 
integrity of distinct areas of the PFC, the medial PFC (mPFC) and orbitofrontal cortex (OFC), 
respectively (Bissonette et al., 2008). This suggests that the deleterious role of the neuropathic 
lesion is mainly restricted to the OFC (discussed in section 3.4). To the best of our knowledge, 
this is the first observation of impaired attentional-set shifting ever reported.    
 
Impulse control in a delay-to-signal task was also affected in the right-sided SNI animals. The 
effect was particularly evident when the delay was incremented from 3 to 7 or 10 seconds.  
This is in agreement with a previous unpublished observation of ours in the classic 5-csrtt. 
Again, impulsivity was only evident when the task demand was increased. Concerning the 
lateralized effect of the lesion, Pais-Vieira and colleagues tested the performance of animals in 
left-sided inflammatory monoarthritis model in the 5-csrtt and, in agreement with our 
observations, failed to demonstrate alterations in impulsive behaviour (see table II; Pais-Vieira 
et al., 2009a).  
 
In the MWM, SNI lesion on either side was not detrimental for the animal performance. In the 
above mentioned study by Ren and colleagues, left-sided SNI animals though presenting an 
increased number of WM errors in the 8-arm, had similar long-term reference memory errors 
when compared to controls (Ren et al., 2011). This result, and considering the construct 
similarities between the two paradigms, is comparable to ours, despite the ethological 
considerations raised before.  
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Table II. Evaluation of cognitive performance in chronic pain models 
trait paradigm species; strain model age side overall effect references 
Sustained attention Delayed nonmatching-
to-position operant task  
rat; Lewis polyarthritis y n/a Increased percentage of incorrect choices 1 to 2 months post pain onset; Cain et al., 1997; Lindner et 
al., 1999 
Attention/memory NORT rat; SD colitis y n/a Decreased attention toward a novel object up to 7 days after pain onset; Millecamps et al., 2004 
Sustained attention/impulsivity 5-csrtt rat; LH monoarthritis y l Decreased accuracy and increased omissions immediately after monoarthritis induction 
(sustained for 10 days); No difference in impulsive responses; 
Pais-Vieira et al., 2009a  
Risk assessment Gambling task rat; SD monoarthritis y l Increased preference for risk choice 5, 21 and 56 days post pain onset; Pais-Vieira et al., 2009b 
Spatial reference memory MWM rat; SD SNL (L5) y n/a Impaired learning performance at day 30;  Hu et al., 2010 
Attention/memory NORT mouse; ddY PSNL y r Decreased attention toward a novel object 7-9 days post PSNL; Kodama et al., 2011 
Working memory 8-arm; NORT rat; SD SNI y l Increased number of WM errors and no differences in spatial reference memory errors in 
the 8-arm at post-surgery days 10-20 and 30-40; Decreased short-term memory and no 
differences in long-term memory at post-surgery days 19 and 20, respectively, in the NORT; 
Ren et al., 2011 
 
Table II. Summary of the literature concerning the effects of chronic pain in cognitive performance in rodent models. Male animals were used in all studies. Abbreviations: 5-
csrtt – 5-choice serial reaction time task; 8-arm – 8-arm radial maze; l – left; LH – Lister Hooded; MWM – Morris water maze; n/a – not applicable (available); NORT – novel 
object recognition test; PSNL – partial sciatic nerve ligation (Seltzer et al., 1990); r – right; SD – Sprague-Dawley; SNI – spared nerve injury (Decosterd and Woolf, 2000); SNL 
– spinal nerve ligation (Kim and Chung, 1992); y – young. 
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3.4. Is the PFC underlying maladaptive behaviour in chronic pain? 
 
 
In an overall appreciation of our behavioural experiments, it is noticeable that a dysfunctional 
PFC could account for the behavioural shifts observed in chronic pain rats. Firstly, the 
behavioural domains affected are known to rely on important contributions from the PFC 
(Miller, 2000; Dalley et al., 2004; Robbins, 2005; Salzman and Fusi, 2010; Diamond, 2011), 
namely working memory (Passingham and Sakai, 2004; Funahashi, 2006; D'Esposito, 2007; 
Galloway et al., 2008; Khan and Muly, 2011), attentional set-shifting (Robbins, 2007), 
impulsivity (Dalley et al., 2008; Kim and Lee, 2011) and emotional behaviour (Cardinal et al., 
2002; Davidson, 2002; Maier and Watkins, 2010; Etkin et al., 2011). Secondly, the PFC is 
morphologically altered in chronic pain conditions (Apkarian et al., 2004; May, 2008). Finally, 
the PFC is functionally lateralized (Cerqueira et al., 2008) and, considering its functional load 
distribution, the behavioural impairments caused by left and right nerve lesions are in 
accordance with the organization of the ascending pathways (see 1.2.2.). Taking this into 
consideration it is important to appraise our data in the context of a PFC contribution. 
 
Brain imaging studies in human subjects consistently indicate that the PFC is morphologically 
altered in a number of chronic pain conditions including chronic back pain (Apkarian et al., 
2004), fibromyalgia (Luerding et al., 2008), chronic complex regional pain syndrome (Geha et 
al., 2008) and myofascial-type temporomandibular disorders (Gerstner et al., 2011). A similar 
observation was also made in a rat model of chronic neuropathic pain (Seminowicz et al., 
2009). The casual relation between pain and the plastic adaptation observed in the PFC has 
been established, the latter depending on the former (and not the opposite) (Rodriguez-Raecke 
et al., 2009). Accordingly, the structural alterations, as well as the cognitive impairments 
associated, were shown to be reversible with an effective analgesic treatment (Seminowicz et 
al., 2011). The reasons for an apparent increased susceptibility of the PFC when compared to 
other cortical areas are not currently understood. In the rat, it has been demonstrated that the 
ventral aspects of the mPFC and the OFC are the only neocortical areas that receive direct 
input from the contralateral spinal cord (Lima, 2009), which may render these areas more 
susceptible to the effects of the nerve lesions. In fact, other second order relay stations of the 
ascending pathways, such as the thalamus and the brainstem, have also been shown to 
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present similar morphological abnormalities (May, 2008), further supporting this hypothesis. 
Finally, the functional integrity of the mPFC and OFC is intimately associated with the 
behavioural domains affected in our experiments (Dalley et al., 2004).  
 
Concerning the lateralized effects of the neuropathic lesion, these can be explained by the 
functional organization of the PFC. Inhibition of the right, but not the left, mPFC (infralimbic 
area) was shown to suppress anxiety-like behaviour (Sullivan and Gratton, 1999, 2002; Wall et 
al., 2004) and stress-induced corticosterone elevation (Sullivan and Gratton, 1999). It is 
therefore tempting to postulate that the deterioration of emotional behaviour we observed in 
the left SNI animals, reflect such organization. As stated before, measurements of circulating 
ACTH and corticosterone indicate that neuropathic animals do not differ from controls in basal 
conditions (Bomholt et al., 2005; Ulrich-Lai et al., 2006; Norman et al., 2009; Yalcin et al., 
2011). However, when challenged with a stress paradigm, the HPA appears to be 
hyperresponsive in left lesioned animals suggesting an impairment of the regulatory 
mechanisms (Ulrich-Lai et al., 2006). New studies are therefore needed concerning this 
hypothesis.  
 
The selective cognitive deficits found in the right-sided animals are, on the other hand, more 
difficult to explain based on a simple lateralization of PFC, because both hemispheres are 
known to contribute to different aspects of cognitive construction/performance (Gazzaniga, 
2000). For instance, when a decision paradigm was applied to patients with either right or left 
PFC lesions, the former show impaired performance in trials where the decision was based on 
incomplete information while the latter were impaired when complete information was provided 
(Goel et al., 2007). An additional example comes from impulsivity studies in humans. Matsuo 
and colleagues (2009) found an inverse correlation between the left/right OFC volume gray 
and motor and nonplanning impulsivity, respectively. The construct of the behavioural 
paradigm employed is therefore determinant when evaluating lateralized frontal dysfunction. 
This probably explains the differences in the WM performance in our experiments and in those 
described by others (Ren et al., 2011).  
 
The PFC hypothesis is also coherent in the context of ageing. This area has been shown to 
present marked morphological alterations, namely cortical atrophy, in aged human individuals 
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(Raz and Rodrigue, 2006). As stated above, similar alterations have been found in chronic pain 
patients (Apkarian et al., 2004) suggesting that a cumulatively effect would result, if the two 
factors co-occur. In fact, in our experiments both control and SNI aged animals presented an 
increased anxiety-like behaviour but this was more marked in the latter, supporting this 
hypothesis. Additionally, there is now available compelling evidence of functional cortical 
asymmetry loss during the aging process (Rossi et al., 2004; Bergerbest et al., 2009), 
explaining the apparently contradictory observation of impaired reversal performance of left-
sided SNI mid-aged animals. 
 
Taken together, these observations give us a compelling indication of the PFC involvement on 
the behavioural shifts occurring after SNI.  
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4. Conclusions and future perspectives 
 
 
It stems from our experimental data that the age at the onset of pain and the lateralization of 
the neuropathic lesion affect the behavioural outcome in emotional and cognitive paradigms. In 
the first case (chapter 2.1.), the presence of chronic pain was shown to further aggravate an 
age-associated deterioration of emotional and cognitive functions while in the second (chapter 
2.2.) emotional and cognitive domains were selectively affected after left- and right-sided 
neuropathic lesions, respectively. Although our data is suggestive of a strong PFC involvement 
in the observed behavioural impairments, the underlying neural substrates remain largely 
unknown. Future studies addressing this issue should include: 
 
i. a chronological evaluation of the manifestations of abnormal emotional and cognitive 
behaviour; this point is essential to establish the temporal window of analyses and/or 
intervention in subsequent experimental studies; 
 
ii. detailed morphological studies of brain areas that by their established role on emotional and 
cognitive behaviours can putatively mediate the behavioural shifts observed in chronic pain. 
For the reasons raised in the previous section, the PFC, namely its medial and ventral 
subdivisions, is a primary candidate area in such studies. These should include, among other 
techniques, volumetric analyses and Golgi stain studies of neural morphology;  
 
iii. electrophysiological recordings of PFC neural activity while performing relevant tasks;   
 	  
125
